Document:

EX-10.10

 Exhibit 10.10 

INOTEK PHARMACEUTICALS CORPORATION 

2014 EMPLOYEE STOCK PURCHASE PLAN 

The purpose of the Inotek Pharmaceuticals Corporation 2014 Employee Stock Purchase Plan (“the Plan”) is to provide eligible
employees of Inotek Pharmaceuticals Corporation (the “Company”) and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase shares of the Company’s common stock, par value $0.01 per share (the
“Common Stock”). The maximum number of shares of Common Stock approved, reserved and available for issuance under the Plan shall be             1 shares of Common Stock, plus on January 1, 2016 and each January 1 thereafter, the number of shares of Common Stock approved, reserved and available for issuance under the Plan shall
be cumulatively increased by the lesser of (i) 600,000 shares of Common Stock or (ii) such number of shares as is necessary to set the number of unissued shares of Common Stock under the Plan at 1% of the Corporation’s
outstanding Common Stock as of January 1 of the applicable year. Notwithstanding the foregoing, the Company’s Board of Directors (the “Board”) may act prior to the first day of any fiscal year to provide that there will be no
January 1 increase in the share reserve for such fiscal year or that the increase in the share reserve for such fiscal year will be a lesser number of shares of Common Stock than would otherwise occur pursuant to the preceding sentence. The
Plan is intended to constitute an “employee stock purchase plan” within the meaning of Section 423(b) of the Internal Revenue Code of 1986, as amended (the “Code”), and shall be interpreted in accordance with that intent.

  

	1 	Number represents 1% of the Corporation’s outstanding common stock after giving effect to the initial public offering (not including any shares purchased by the underwriters pursuant to their overallotment option).

 1. Administration. The Plan will be administered by the person or persons (the
“Administrator”) appointed by the Board for such purpose. The Administrator has authority at any time to: (i) adopt, alter and repeal such rules, guidelines and practices for the administration of the Plan and for its own acts and
proceedings as it shall deem advisable; (ii) interpret the terms and provisions of the Plan; (iii) make all determinations it deems advisable for the administration of the Plan; (iv) decide all disputes arising in connection with the
Plan; and (v) otherwise supervise the administration of the Plan. All interpretations and decisions of the Administrator shall be binding on all persons, including the Company and the Participants. No member of the Board or individual
exercising administrative authority with respect to the Plan shall be liable for any action or determination made in good faith with respect to the Plan or any option granted hereunder. 

2. Offerings. The Company will make one or more offerings to eligible employees to purchase Common Stock under the Plan
(“Offerings”). Unless otherwise determined by the Administrator, the initial Offering will begin on January 1st of the year designated by the Administrator and will end on the
following June 30th (the “Initial Offering”). Thereafter, unless otherwise determined by the Administrator, an Offering will begin on the first business day occurring on or
after each January 1st and July 1st and will end on the last business day occurring on or before the following June 30th and December 31st, respectively. The Administrator may, in its discretion, designate a different period for any Offering, provided that no
Offering shall exceed one year in duration or overlap any other Offering. 
 3. Eligibility. All individuals classified as employees
on the payroll records of the Company and each Designated Subsidiary are eligible to participate in any one or more of the Offerings under the Plan, provided that as of the first day of the applicable Offering (the “Offering Date”) they
are customarily employed by the Company or a Designated Subsidiary for more than 20 hours a week and have completed at least six months of employment. Notwithstanding any other provision herein, individuals who are not contemporaneously

  
 2 

 
classified as employees of the Company or a Designated Subsidiary for purposes of the Company’s or applicable Designated Subsidiary’s payroll system are not considered to be eligible
employees of the Company or any Designated Subsidiary and shall not be eligible to participate in the Plan. In the event any such individuals are reclassified as employees of the Company or a Designated Subsidiary for any purpose, including, without
limitation, common law or statutory employees, by any action of any third party, including, without limitation, any government agency, or as a result of any private lawsuit, action or administrative proceeding, such individuals shall,
notwithstanding such reclassification, remain ineligible for participation. Notwithstanding the foregoing, the exclusive means for individuals who are not contemporaneously classified as employees of the Company or a Designated Subsidiary on the
Company’s or Designated Subsidiary’s payroll system to become eligible to participate in this Plan is through an amendment to this Plan, duly executed by the Company, which specifically renders such individuals eligible to participate
herein. 
 4. Participation. 

(a) Participants in Offerings. An eligible employee who is not a Participant on any Offering Date may participate in such Offering by
submitting an enrollment form to his or her appropriate payroll location at least 15 business days before the Offering Date (or by such other deadline as shall be established by the Administrator for the Offering). 

(b) Enrollment. The enrollment form will (a) state a whole percentage to be deducted from an eligible employee’s Compensation
(as defined in Section 11) per pay period, (b) authorize the purchase of Common Stock in each Offering in accordance with the terms of the Plan and (c) specify the exact name or names in which shares of Common Stock purchased for such
individual are to be issued pursuant to Section 10. An employee who does not enroll in 

  
 3 

 
accordance with these procedures will be deemed to have waived the right to participate. Unless a Participant files a new enrollment form or withdraws from the Plan, such Participant’s
deductions and purchases will continue at the same percentage of Compensation for future Offerings, provided he or she remains eligible. 

(c) Notwithstanding the foregoing, participation in the Plan will neither be permitted nor be denied contrary to the requirements of the Code.

 5. Employee Contributions. Each eligible employee may authorize payroll deductions at a minimum of one percent up to a maximum of
10 percent of such employee’s Compensation for each pay period. The Company will maintain book accounts showing the amount of payroll deductions made by each Participant for each Offering. No interest will accrue or be paid on payroll
deductions. 
 6. Deduction Changes. Except as may be determined by the Administrator in advance of an Offering, a Participant may
elect to increase his or her payroll deduction (subject to the limitations in Section 5) not more than twice during an Offering and may elect to decrease his or her payroll deduction (subject to the limitations in Section 5) as many times
as desired during an Offering, in each case by filing a new enrollment form at least 15 business days before the next payroll period for which such election is to be effective (or by such other deadline as shall be established by the Administrator).
A Participant may also increase or decrease his or her payroll deduction with respect to the next Offering (subject to the limitations of Section 5) by filing a new enrollment form at least 15 business days before the next Offering Date (or by
such other deadline as shall be established by the Administrator for the Offering). The Administrator may, in advance of any Offering, change or establish other rules with respect to a Participant’s ability to increase, decrease or terminate
his or her payroll deduction during an Offering. 

  
 4 

 7. Withdrawal. A Participant may withdraw from participation in the Plan by delivering a
written notice of withdrawal to his or her appropriate payroll location. The Participant’s withdrawal will be effective as of the next business day. Following a Participant’s withdrawal, the Company will promptly refund such
individual’s entire account balance under the Plan to him or her (after payment for any Common Stock purchased before the effective date of withdrawal). Partial withdrawals are not permitted. Such an employee may not begin participation again
during the remainder of the Offering, but may enroll in a subsequent Offering in accordance with Section 4. 
 8. Grant of
Options. On each Offering Date, the Company will grant to each eligible employee who is then a Participant in the Plan an option (“Option”) to purchase on the last day of such Offering (the “Exercise Date”), at the Option
Price hereinafter provided for, the lowest of (a) a number of shares of Common Stock determined by dividing such Participant’s accumulated payroll deductions on such Exercise Date by the lower of (i) 85 percent of the Fair Market
Value of the Common Stock on the Offering Date, or (ii) 85 percent of the Fair Market Value of the Common Stock on the Exercise Date; (b) 5,000 shares of Common Stock; or (c) such other lesser maximum number of shares as shall have
been established by the Administrator in advance of the Offering; provided, however, that such Option shall be subject to the limitations set forth below. Each Participant’s Option shall be exercisable only to the extent of such
Participant’s accumulated payroll deductions on the Exercise Date. The purchase price for each share purchased under each Option (the “Option Price”) will be 85 percent of the Fair Market Value of the Common Stock on the Offering Date
or the Exercise Date, whichever is less. 

  
 5 

 Notwithstanding the foregoing, no Participant may be granted an option hereunder if such
Participant, immediately after the option was granted, would be treated as owning stock possessing 5 percent or more of the total combined voting power or value of all classes of stock of the Company or any Parent or Subsidiary (as defined in
Section 11). For purposes of the preceding sentence, the attribution rules of Section 424(d) of the Code shall apply in determining the stock ownership of a Participant, and all stock which the Participant has a contractual right to
purchase shall be treated as stock owned by the Participant. In addition, no Participant may be granted an Option which permits his or her rights to purchase stock under the Plan, and any other employee stock purchase plan of the Company and its
Parents and Subsidiaries, to accrue at a rate which exceeds $25,000 of the fair market value of such stock (determined on the option grant date or dates) for each calendar year in which the Option is outstanding at any time. The purpose of the
limitation in the preceding sentence is to comply with Section 423(b)(8) of the Code and shall be applied taking Options into account in the order in which they were granted. 

9. Exercise of Option and Purchase of Shares. Each employee who continues to be a Participant in the Plan on the Exercise Date shall be
deemed to have exercised his or her Option on such date and shall acquire from the Company such number of whole shares of Common Stock reserved for the purpose of the Plan as his or her accumulated payroll deductions on such date will purchase at
the Option Price, subject to any other limitations contained in the Plan. Any amount remaining in a Participant’s account at the end of an Offering solely by reason of the inability to purchase a fractional share will be carried forward to the
next Offering; any other balance remaining in a Participant’s account at the end of an Offering will be refunded to the Participant promptly. 

  
 6 

 10. Issuance of Certificates. Certificates representing shares of Common Stock purchased
under the Plan may be issued only in the name of the employee, in the name of the employee and another person of legal age as joint tenants with rights of survivorship, or in the name of a broker authorized by the employee to be his, her or their,
nominee for such purpose. 
 11. Definitions. 

The term “Compensation” means the amount of total cash compensation, prior to salary reduction pursuant to Sections 125, 132(f)
or 401(k) of the Code, including base pay, overtime, commissions, and incentive or bonus awards, but excluding allowances and reimbursements for expenses such as relocation allowances or travel expenses, income or gains on the exercise of Company
stock options, and similar items. 
 The term “Designated Subsidiary” means any present or future Subsidiary (as defined below)
that has been designated by the Board to participate in the Plan. The Board may so designate any Subsidiary, or revoke any such designation, at any time and from time to time, either before or after the Plan is approved by the stockholders. 

The term “Fair Market Value of the Common Stock” on any given date means the fair market value of the Common Stock determined in
good faith by the Administrator; provided, however, that if the Common Stock is admitted to quotation on the National Association of Securities Dealers Automated Quotation System (“NASDAQ”), NASDAQ Global Market or another national
securities exchange, the determination shall be made by reference to the closing price on such date. If there is no closing price for such date, the determination shall be made by reference to the last date preceding such date for which there is a
closing price. 
 The term “Parent” means a “parent corporation” with respect to the Company, as defined in
Section 424(e) of the Code. 
 The term “Participant” means an individual who is eligible as determined in Section 3 and
who has complied with the provisions of Section 4. 

  
 7 

 The term “Subsidiary” means a “subsidiary corporation” with respect to the
Company, as defined in Section 424(f) of the Code. 
 12. Rights on Termination of Employment. If a Participant’s
employment terminates for any reason before the Exercise Date for any Offering, no payroll deduction will be taken from any pay due and owing to the Participant and the balance in the Participant’s account will be paid to such Participant or,
in the case of such Participant’s death, to his or her designated beneficiary as if such Participant had withdrawn from the Plan under Section 7. An employee will be deemed to have terminated employment, for this purpose, if the
corporation that employs him or her, having been a Designated Subsidiary, ceases to be a Subsidiary, or if the employee is transferred to any corporation other than the Company or a Designated Subsidiary. An employee will not be deemed to have
terminated employment for this purpose, if the employee is on an approved leave of absence for military service or sickness or for any other purpose approved by the Company, if the employee’s right to reemployment is guaranteed either by a
statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Administrator otherwise provides in writing. 

13. Special Rules. Notwithstanding anything herein to the contrary, the Administrator may adopt special rules applicable to the
employees of a particular Designated Subsidiary, whenever the Administrator determines that such rules are necessary or appropriate for the implementation of the Plan in a jurisdiction where such Designated Subsidiary has employees; provided that
such rules are consistent with the requirements of Section 423(b) of the Code. Any special rules established pursuant to this Section 13 shall, to the extent possible, result in the employees subject to such rules having substantially the
same rights as other Participants in the Plan. 

  
 8 

 14. Optionees Not Stockholders. Neither the granting of an Option to a Participant nor the
deductions from his or her pay shall constitute such Participant a holder of the shares of Common Stock covered by an Option under the Plan until such shares have been purchased by and issued to him or her. 

15. Rights Not Transferable. Rights under the Plan are not transferable by a Participant other than by will or the laws of descent and
distribution, and are exercisable during the Participant’s lifetime only by the Participant. 
 16. Application of Funds. All
funds received or held by the Company under the Plan may be combined with other corporate funds and may be used for any corporate purpose. 

17. Adjustment in Case of Changes Affecting Common Stock. In the event of a subdivision of outstanding shares of Common Stock, the
payment of a dividend in Common Stock or any other change affecting the Common Stock, the number of shares approved for the Plan and the share limitation set forth in Section 8 shall be equitably or proportionately adjusted to give proper
effect to such event. 
 18. Amendment of the Plan. The Board may at any time and from time to time amend the Plan in any respect,
except that without the approval within 12 months of such Board action by the stockholders, no amendment shall be made increasing the number of shares approved for the Plan or making any other change that would require stockholder approval in order
for the Plan, as amended, to qualify as an “employee stock purchase plan” under Section 423(b) of the Code. 
 19.
Insufficient Shares. If the total number of shares of Common Stock that would otherwise be purchased on any Exercise Date plus the number of shares purchased under previous Offerings under the Plan exceeds the maximum number of shares
issuable under the Plan, the shares then available shall be apportioned among Participants in proportion to the amount of payroll deductions accumulated on behalf of each Participant that would otherwise be used to purchase Common Stock on such
Exercise Date. 

  
 9 

 20. Termination of the Plan. The Plan may be terminated at any time by the Board. Upon
termination of the Plan, all amounts in the accounts of Participants shall be promptly refunded. The Plan shall automatically terminate on the tenth anniversary of the date the Plan was approved by the Company’s stockholders 

21. Governmental Regulations. The Company’s obligation to sell and deliver Common Stock under the Plan is subject to obtaining all
governmental approvals required in connection with the authorization, issuance, or sale of such stock. 
 22. Governing Law. This
Plan and all Options and actions taken thereunder shall be governed by, and construed in accordance with, the laws of the State of Delaware, applied without regard to conflict of law principles. 

23. Issuance of Shares. Shares may be issued upon exercise of an Option from authorized but unissued Common Stock, from shares held in
the treasury of the Company, or from any other proper source. 
 24. Tax Withholding. Participation in the Plan is subject to any
minimum required tax withholding on income of the Participant in connection with the Plan. Each Participant agrees, by entering the Plan, that the Company and its Subsidiaries shall have the right to deduct any such taxes from any payment of any
kind otherwise due to the Participant, including shares issuable under the Plan. 

  
 10 

 25. Notification Upon Sale of Shares. Each Participant agrees, by entering the Plan, to
give the Company prompt notice of any disposition of shares purchased under the Plan where such disposition occurs within two years after the date of grant of the Option pursuant to which such shares were purchased. 

26. Effective Date and Approval of Shareholders. The Plan shall take effect on the later of the date it is adopted by the Board and the
date it is approved by the holders of a majority of the votes cast at a meeting of stockholders at which a quorum is present or by written consent of the stockholders. 

  
 11Exhibit 10.1

 

COMMON STOCK PURCHASE
AGREEMENT

 

This COMMON
STOCK PURCHASE AGREEMENT is made and entered into as of February 11, 2015 (this “Agreement”),
by and between Beaufort Capital Partners, LLC, a New York limited liability company (the “Investor”),
and Soul and Vibe Interactive Inc., a corporation organized and existing under the laws of the state of Nevada (the “Company”). 

 

RECITALS

 

WHEREAS, the
parties desire that, upon the terms and subject to the conditions and limitations set forth herein, the Company may issue and
sell to the Investor, from time to time as provided herein, and the Investor shall purchase from the Company, up to $2,000,000
of newly issued shares of the Company’s common stock, $0.001 par value (“Common Stock”); 

 

WHEREAS, such
investments will be made in reliance upon the provisions of the Securities Act and upon such other exemption from the registration
requirements of the Securities Act as may be available with respect to any or all of the investments in Common Stock to be made
hereunder; and

 

WHEREAS, the
parties hereto are concurrently entering into a Registration Rights Agreement in the form of Exhibit A  hereto
(the “Registration Rights Agreement”), pursuant to which the Company shall register the Registrable
Securities (as defined in the Registration Rights Agreement), upon the terms and subject to the conditions set forth therein;

 

NOW, THEREFORE, the
parties hereto, intending to be legally bound, hereby agree as follows:

 

ARTICLE
I

DEFINITIONS

 

Capitalized terms
used in this Agreement shall have the meanings ascribed to such terms in Annex I hereto, and hereby made a part
hereof, or as otherwise set forth in this Agreement.

 

ARTICLE
II

PURCHASE AND SALE OF COMMON STOCK

 

Section 2.1.           Purchase
and Sale of Stock.  Upon the terms and subject to the conditions of this Agreement, during the Investment Period,
the Company in its discretion may issue and sell to the Investor, and the Investor shall purchase from the Company, up to $2,000,000
(the “Total Commitment”) of duly authorized, validly issued, fully paid and nonassessable shares of
Common Stock (the “Aggregate Limit”), by the delivery to the Investor of Draw Down Notices as provided
in Article III hereof.

 

    	1

    	 

    

 

Section 2.2.         
 Closing Date; Settlement Dates. This Agreement shall become effective and binding (the “Closing”)
upon the delivery of counterpart signature pages of this Agreement and the Registration Rights Agreement executed by each of the
parties hereto and thereto, and the delivery of all other documents, instruments and writings required to be delivered at the
Closing, in each case as provided in Section 7.1, to the offices of Sichenzia Ross Friedman Ference LLP, 61 Broadway, New York,
NY 10006, at 5:00 p.m., New York City time, on the Closing Date. In consideration of and in express reliance upon the representations,
warranties and covenants contained in, and upon the terms and subject to the conditions of, this Agreement, during the Investment
Period the Company shall issue and sell to the Investor, and the Investor shall purchase from the Company, the Shares in respect
of each Draw Down. The issuance and sale of Shares to the Investor pursuant to any Draw Down shall occur on the applicable Settlement
Date in accordance with Section 3.5, provided  that all of the conditions precedent thereto set forth in
Article VII theretofore shall have been fulfilled on or prior to such Settlement Date.

 

Section 2.3.         
 Initial Public Announcements and Required Filings.  The Company shall, at or before 8:30 a.m., New York
City time, on the second Trading Day after the Closing, issue a press release (the “Press Release”)
reasonably acceptable to the Investor disclosing the execution of this Agreement and the Registration Rights Agreement by the
Company and the Investor, and briefly describing the transactions contemplated thereby. At or before 8:30 a.m., New York City
time, on the second Trading Day following the Closing Date, the Company shall file a Current Report on Form 8-K describing all
the material terms of the transactions contemplated by the Transaction Documents in the form required by the Exchange Act and
attaching copies of each of this Agreement, the Registration Rights Agreement and the Press Release as exhibits thereto (including
all exhibits thereto, the “Current Report”). From and after the issuance of the Press Release and the
filing of the Current Report, the Company shall have disclosed all material, nonpublic information delivered to the Investor (or
the Investor’s representatives or agents) by the Company or any of its Subsidiaries, or any of their respective officers,
directors, employees, agents or representatives (if any) in connection with the transactions contemplated by the Transaction Documents.
The Investor covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company
as described in this Section 2.3, the Investor will maintain the confidentiality of all disclosures made to it in connection with
the transactions contemplated by the Transaction Documents (including the existence and terms of the transactions), except that
the Investor may disclose the terms of such transactions to its financial, accounting, legal and other advisors (provided that
the Investor directs such Persons to maintain the confidentiality of such information). The Company shall prepare and file with
the Commission the Registration Statement (including the Prospectus) covering only the resale by the Investor of the Registrable
Securities in accordance with the Securities Act and the Registration Rights Agreement.  At or before 8:30 a.m. (New York
City time) on the Trading Day immediately following the Effective Date, the Company shall file with the Commission in accordance
with Rule 424(b) under the Securities Act the final Prospectus to be used in connection with sales pursuant to the Registration
Statement. If the transactions contemplated by any Draw Down are material to the Company (individually or collectively with all
other prior Draw Downs, the consummation of which have not previously been reported in any Prospectus Supplement filed with the
Commission under Rule 424(b) under the Securities Act or in any report, statement or other document filed by the Company with
the Commission under the Exchange Act), or if otherwise required under the Securities Act (or the interpretations of the Commission
thereof), as may be reasonably determined by the Company, then, the Company shall promptly file with the Commission a
Prospectus Supplement pursuant to Rule 424(b) under the Securities Act with respect to such transactions or Draw Downs. To the
extent not previously disclosed in the Prospectus or a Prospectus Supplement, the Company shall disclose in its Quarterly Reports
on Form 10-Q and in its Annual Reports on Form 10-K the information described in the immediately preceding sentence relating to
all Draw Down(s) consummated during the relevant fiscal quarter, and include each such Quarterly Report on Form 10-Q and Annual
Report on Form 10-K in a Prospectus Supplement and file such Prospectus Supplement with the Commission under Rule 424(b) under
the Securities Act. 

 

    	2

    	 

    

 

ARTICLE
III

DRAW DOWN TERMS

 

Subject to the satisfaction
of the conditions set forth in this Agreement, the parties agree as follows:

 

Section 3.1.         
 Draw Down Notice.  From time to time during the Investment Period, the Company may, in its sole discretion,
provide to the Investor a Draw Down Notice, substantially in the form attached hereto as Exhibit B (the “Draw
Down Notice”). A Draw Down Notice shall be deemed delivered on (i) the Trading Day it is received by email
(to the address set forth in Section 10.4 herein) by the Investor if such notice is received prior to 5:00 pm Eastern Time, or
(ii) the immediately succeeding Trading Day if it is received by email after 5:00 pm Eastern Time on a Trading Day or at
any time on a day which is not a Trading Day (the “Draw Down Exercise Date”). No Draw Down Notice may
be deemed delivered on a day that is not a Trading Day. The Company acknowledges and agrees that the Investor shall be entitled
to treat any email it receives from officers whose email addresses are identified by the Company purporting to be a Draw Down
Notice as a duly executed and authorized Draw Down Notice from the Company.  The Draw Down Notice shall specify the Draw
Down Amount Requested (which shall not exceed the Maximum Draw Down Amount Requested). Upon the terms and subject to the conditions
of this Agreement, the Investor is obligated to accept each Draw Down Notice prepared and delivered in accordance with the provisions
of this Agreement and shall purchase from the Company the Shares subject to such Draw Down Notice at the applicable Discount Price
on the applicable Settlement Date. In addition, the Common Stock must be DWAC eligible and sent to the Investor in electronic
form, instead of certificate form. In the event that the Investor sends written acceptance of accepting a physical certificate,
all fees and expenses for this certificate will be paid by the Company. 

 

Section 3.2.         
 Intentionally Left Blank.

 

Section 3.3.         
 Reduction of Commitment.  On each Settlement Date, the Investor’s Total Commitment under this Agreement
automatically shall be reduced, on a dollar-for-dollar basis, by the total dollar amount of shares of Common Stock issued by the
Company on such Settlement Date or in connection therewith.

 

    	3

    	 

    

 

Section 3.4.         
 Maximum Draw Down Amount.  The maximum number of Shares that the Investor shall be required to purchase
for any Draw Down shall in no event exceed (i) 300% of the average daily share volume of the Common Stock in the five trading
days immediately preceding the Draw Down Notice, (ii) such number of shares as shall cause the aggregate holdings of the Investor’s
shares of common stock of the Company to exceed the Ownership Limitation set forth in Section 3.7 below, or (iii) the aggregate
offering price or number of shares of Common Stock available for issuance under a Registration Statement (the “Registration
Limitation”) (the “Maximum Draw Down Amount Requested”).

 

Section 3.5.          Intentionally
Left Blank.

 

Section 3.6.         Settlement.
Within five (5) Trading Days of Delivery of a Draw Down Notice, the Company shall, or shall cause its transfer agent to, electronically
transfer the Shares purchased by the Investor by crediting the Investor’s or its designees’ account (provided the
Investor shall have given the Company written notice of such designee prior to the Settlement Date) at DTC through its Deposit/Withdrawal
at Custodian (“DWAC”) system, which Shares shall be freely tradable and transferable and without restriction
on resale pursuant to the Registration Statement (the “Settlement Date”). Once such Shares have been
accepted by the Investor, the Investor shall immediately deliver to the Company the amount of the Draw Down by wire transfer of
immediately available funds. On or prior to the Settlement Date, each of the Company and the Investor shall deliver to the other
all documents, instruments and writings required to be delivered by either of them pursuant to Section 7.2 below in order
to implement and effect the transactions contemplated herein.

 

Section 3.6.         Intentionally
Left Blank.

 

Section 3.7.         
 Certain Limitations. Notwithstanding anything to the contrary contained in this Agreement, in no event may
the Company issue a Draw Down Notice to the extent that (i) the Draw Down Amount Requested in such Draw Down Notice exceeds the
Maximum Draw Down Amount Requested, (ii) the sale of Shares pursuant to such Draw Down Notice would cause the Company to issue
or sell or the Investor to acquire or purchase a number of shares of Common Stock which, when aggregated with shares of Common
Stock issued pursuant to all Draw Down Amounts paid by the Investor pursuant to all prior Draw Down Notices issued under this
Agreement, would exceed the Aggregate Limit, or (iii) the sale of Shares pursuant to such Draw Down Notice would cause the Company
to sell or the Investor to purchase a number of shares of Common Stock which, when aggregated with all other shares of Common
Stock then beneficially owned (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder)
by the Investor and its Affiliates, would result in the beneficial ownership by the Investor or any of its Affiliates of more
than 4.99% of the then issued and outstanding shares of Common Stock (the “Ownership Limitation”) (as
of the date of this Agreement, Investor and its affiliates held zero (0%) percent of the outstanding Common Stock). If the Company
issues a Draw Down Notice in which the Draw Down Amount Requested exceeds the Maximum Draw Down Amount Requested, such Draw Down
Notice shall be void ab initio to the extent the Draw Down Amount Requested exceeds the Maximum Draw Down Amount
Requested. If the Company issues a Draw Down Notice that otherwise would require the Investor to purchase shares of Common Stock
which would cause the aggregate purchases of Common Stock by the Investor under this Agreement to exceed the Aggregate Limit,
such Draw Down Notice shall be void ab initio to the extent of the amount by which the dollar value of shares
of Common Stock otherwise issuable pursuant to such Draw Down Notice, together with all Draw Down Amounts paid by the Investor
pursuant to all prior Draw Down Notices issued under this Agreement, would exceed the Aggregate Limit. If the Company issues a
Draw Down Notice that otherwise would require the Investor to purchase shares of Common Stock which would cause the aggregate
number of shares of Common Stock then beneficially owned (as calculated pursuant to Section 13(d) of the Exchange Act and Rule
13d-3 promulgated thereunder) by the Investor and its Affiliates to exceed the Ownership Limitation, such Draw Down Notice shall
be void ab initio to the extent of the amount by which the number of shares of Common Stock otherwise issuable
pursuant to such Draw Down Notice, together with all shares of Common Stock then beneficially owned by the Investor and its Affiliates,
would exceed the Ownership Limitation. 

 

    	4

    	 

    

 

Section 3.8.       Intentionally
Left Blank.

 

Section 3.9.       Intentionally
Left Blank. 

 

Section 3.10.    Overall
Limit on Issuable Common Stock. Notwithstanding anything contained herein to the contrary, if during the Commitment
Period the Company becomes listed on an exchange that limits the number of shares of Common Stock that may be issued without shareholder
approval, then the total number of Shares issuable by the Company and purchasable by the Investor pursuant to this Agreement shall
not exceed that number of shares of Common Stock that may be issuable without shareholder approval (the “Maximum Common
Stock Issuance”).  If such issuance of Shares could cause a delisting on the Trading Market,
then the Maximum Common Stock Issuance shall first be approved by the Company's shareholders in accordance with applicable law
and the By-laws and Articles of Incorporation of the Company. The parties understand and agree that the Company's failure to seek
or obtain such shareholder approval shall in no way adversely affect the validity and due authorization of the issuance and sale
of Shares in accordance with the terms and conditions hereof to the Investor or the Investor's obligation in accordance with the
terms and conditions hereof to purchase a number of Shares in the aggregate up to the Maximum Common Stock Issuance limitation,
and that such approval pertains only to the applicability of the Maximum Common Stock Issuance limitation provided in this Section
3.10.

 

Section 3.11. Valuation
Event. The Company agrees that it shall not take any action that would result in a Valuation Event occurring during a
Pricing Period. Valuation Event shall mean an event in which the Company at any time during a Pricing Period takes any of the
following actions: (i) subdivides or combines its Common Stock or (ii) pays a dividend on its shares of Common Stock or makes
any other purchase of its shares of Common Stock.

 

ARTICLE
IV

REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE INVESTOR

 

The Investor hereby
makes the following representations, warranties and covenants to the Company:

 

    	5

    	 

    

  

Section 4.1.         
 Organization and Standing of the Investor.  The Investor is a limited liability company duly organized,
validly existing and in good standing under the laws of the State of New York. 

 

Section 4.2.         
 Authorization and Power.  The Investor has the requisite company power and authority to enter into and perform
its obligations under this Agreement and the Registration Rights Agreement and to purchase or acquire the Securities in accordance
with the terms hereof. The execution, delivery and performance by the Investor of this Agreement and the Registration Rights Agreement
and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary corporate
action, and no further consent or authorization of the Investor, its Board of Managers or its members is required. Each of this
Agreement and the Registration Rights Agreement has been duly executed and delivered by the Investor and constitutes a valid and
binding obligation of the Investor enforceable against it in accordance with its terms, except as such enforceability may be limited
by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, conservatorship, receivership, or similar laws
relating to, or affecting generally the enforcement of, creditor’s rights and remedies or by other equitable principles
of general application (including any limitation of equitable remedies).

 

Section 4.3.         
 No Conflicts.  The execution, delivery and performance by the Investor of this Agreement and the Registration
Rights Agreement and the consummation by the Investor of the transactions contemplated hereby and thereby do not and shall not
(i) result in a violation of such Investor’s charter documents, operating agreement or other applicable organizational instruments,
(ii) conflict with, constitute a default (or an event which, with notice or lapse of time or both, would become a default) under,
or give rise to any rights of termination, amendment, acceleration or cancellation of, any material agreement, mortgage, deed
of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which the Investor is a party or is bound,
(iii) create or impose any lien, charge or encumbrance on any property of the Investor under any agreement or any commitment to
which the Investor is party or under which the Investor is bound or under which any of its properties or assets are bound, or
(iv) result in a violation of any federal, state, local or foreign statute, rule, or regulation, or any order, judgment or decree
of any court or governmental agency applicable to the Investor or by which any of its properties or assets are bound or affected,
except, in the case of clauses (ii), (iii) and (iv), for such conflicts, defaults, terminations, amendments, acceleration, cancellations
and violations as would not, individually or in the aggregate, prohibit or otherwise interfere with, in any material respect,
the ability of the Investor to enter into and perform its obligations under this Agreement and the Registration Rights Agreement.
The Investor is not required under any applicable federal, state, local or foreign law, rule or regulation to obtain any consent,
authorization or order of, or make any filing or registration with, any court or governmental agency in order for it to execute,
deliver or perform any of its obligations under this Agreement and the Registration Rights Agreement or to purchase the Securities
in accordance with the terms hereof; provided, however, that for purposes of the representation made in
this sentence, the Investor is assuming and relying upon the accuracy of the relevant representations and warranties and the compliance
with the relevant covenants and agreements of the Company in the Transaction Documents to which it is a party.

 

    	6

    	 

    

 

Section 4.4.         
Investment Purpose. The Investor is acquiring the Securities for its own account, for investment purposes and
not with a view towards, or for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered
under or exempt from the registration requirements of the Securities Act; provided, however, that by making
the representations herein, the Investor does not agree, or make any representation or warranty, to hold any of the Securities
for any minimum or other specific term and reserves the right to dispose of the Securities at any time in accordance with or pursuant
to a registration statement or an exemption under the Securities Act. The Investor does not presently have any agreement or understanding,
directly or indirectly, with any Person to distribute any of the Securities.

 

Section 4.5.         
Accredited Investor Status. The Investor is an “accredited investor” as that term is defined in Rule
501(a) of Regulation D.

 

Section 4.6.         Intentionally left blank.

 

Section 4.7.         
Information. All materials relating to the business, financial condition, management and operations of the Company
and materials relating to the offer and sale of the Securities which have been requested by the Investor have been furnished or
otherwise made available to the Investor or its advisors, including, without limitation, the Commission Documents.  The Investor
understands that its investment in the Securities involves a high degree of risk. The Investor is able to bear the economic risk
of an investment in the Securities and has such knowledge and experience in financial and business matters that it is capable
of evaluating the merits and risks of a proposed investment in the Securities. The Investor and its advisors have been afforded
the opportunity to ask questions of and receive answers from representatives of the Company concerning the financial condition
and business of the Company and other matters relating to an investment in the Securities.  Neither such inquiries nor any
other due diligence investigations conducted by the Investor or its advisors, if any, or its representatives shall modify, amend
or affect the Investor’s right to rely on the Company’s representations and warranties contained in this Agreement
or in any other Transaction Document to which the Company is a party or the Investor’s right to rely on any other document
or instrument executed and/or delivered in connection with this Agreement or the consummation of the transaction contemplated
hereby. The Investor has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment
decision with respect to its acquisition of the Securities. The Investor understands that it (and not the Company) shall be responsible
for its own tax liabilities that may arise as a result of this investment or the transactions contemplated by this Agreement.

 

Section 4.8.           Intentionally
left blank.

 

Section 4.9.         
No General Solicitation. The Investor is not purchasing the Securities as a result of any form of general solicitation
or general advertising (within the meaning of Regulation D) in connection with the offer or sale of the Securities.

 

Section 4.10.      
Not an Affiliate. The Investor is not an officer, director or an Affiliate of the Company.

 

    	7

    	 

    

 

Section 4.11.     
Statutory Underwriter Status. The Investor acknowledges that it will be disclosed as an “underwriter”
and a “selling stockholder” in the Registration Statement and in any Prospectus contained therein to the extent required
by applicable law and to the extent the Prospectus is related to the resale of Registrable Securities.

 

Section 4.12.     
 Resales of Securities. The Investor represents, warrants and covenants that unless the Securities are eligible
for resale pursuant to Rule 144, it will resell such Securities only pursuant to the Registration Statement, in a manner described
under the caption “Plan of Distribution” in the Registration Statement, and in a manner in compliance with all applicable
U.S. federal and state securities laws, rules and regulations, including, without limitation, any applicable prospectus delivery
requirements of the Securities Act.

 

Section
4.13.        Trading Activities. The Investor’s trading activities with
respect to the Common Stock shall be in compliance with all applicable securities laws, rules and regulations and the rules and
regulations of the Principal Market on which the Common Stock is listed or traded. Investor makes no representations or covenants
that it will not engage in trading in the securities of the Company, other than the Investor will not engage in any short sales
of the Common Stock, or other similar activity that profits on the decline in the price of Common Stock, at any time during the
Agreement. Nothing contained in this Agreement shall be deemed a representation or warranty by the Investor to hold any Stock
for any period of time. The Company acknowledges and agrees that transactions in its securities by the Investor may impact the
market price of the Stock, including during periods when the prices at which the Company may be required to issue Investor’s
stock are determined.

 

ARTICLE
V

REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY

 

Except as set forth
in the disclosure schedule delivered by the Company to the Investor (which is hereby incorporated by reference in, and constitutes
an integral part of, this Agreement) (the “Disclosure Schedule”), the Company hereby makes the following
representations, warranties and covenants to the Investor:

 

Section 5.1.         Organization, Good Standing and Power.  The Company and each of its Subsidiaries is a corporation duly organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation and has the requisite corporate
power and authority to own, lease and operate its properties and assets and to conduct its business as it is now being conducted
and as presently proposed to be conducted. The Company and each Subsidiary is duly qualified as a foreign corporation to do business
and is in good standing in every jurisdiction in which the nature of the business conducted or property owned by it makes such
qualification necessary, except for any jurisdiction in which the failure to be so qualified would not have a Material Adverse
Effect. 

 

    	8

    	 

    

  

Section 5.2.         
Authorization, Enforcement.  The Company has the requisite corporate power and authority to enter into and
perform its obligations under each of the Transaction Documents to which it is a party and to issue the Securities in accordance
with the terms hereof and thereof. Except for approvals of the Company’s Board of Directors or a committee thereof as may
be required in connection with any issuance and sale of Securities to the Investor hereunder (which approvals shall be obtained
prior to the delivery of any Draw Down Notice), the execution, delivery and performance by the Company of each of the Transaction
Documents to which it is a party and the consummation by it of the transactions contemplated hereby and thereby have been duly
and validly authorized by all necessary corporate action, and no further consent or authorization of the Company, its Board of
Directors or its stockholders is required. Each of the Transaction Documents to which the Company is a party has been duly executed
and delivered by the Company and constitutes a valid and binding obligation of the Company enforceable against the Company in
accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation, conservatorship, receivership or similar laws relating to, or affecting generally the enforcement of,
creditor’s rights and remedies or by other equitable principles of general application (including any limitation of equitable
remedies).

 

Section 5.3.         
Capitalization and Voting Rights.  The authorized capital stock of the Company and the shares thereof issued
and outstanding were as set forth in the Commission Documents as of the dates reflected therein. All of the outstanding shares
of Common Stock have been duly authorized and validly issued, and are fully paid and nonassessable. Except as set forth in the
Commission Documents, this Agreement and the Registration Rights Agreement, there are no agreements or arrangements under which
the Company is obligated to register the sale of any securities under the Securities Act. Except as set forth in the Commission
Documents, no shares of Common Stock are entitled to preemptive rights and there are no outstanding debt securities and no contracts,
commitments, understandings, or arrangements by which the Company is or may become bound to issue additional shares of the capital
stock of the Company or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating
to, or securities or rights convertible into or exchangeable for, any shares of capital stock of the Company other than those
issued or granted in the ordinary course of business pursuant to the Company’s equity incentive and/or compensatory plans
or arrangements. Except for customary transfer restrictions contained in agreements entered into by the Company to sell restricted
securities or as set forth in the Commission Documents, the Company is not a party to, and it has no Knowledge of, any agreement
restricting the voting or transfer of any shares of the capital stock of the Company. Except as set forth in the Commission Documents,
the offer and sale of all capital stock, convertible or exchangeable securities, rights, warrants or options of the Company issued
prior to the Closing Date complied with all applicable federal and state securities laws, and no stockholder has any right of
rescission or damages or any “put” or similar right with respect thereto that would have a Material Adverse Effect.
Except as set forth in the Commission Documents, there are no securities or instruments containing anti-dilution or similar provisions
that will be triggered by this Agreement or any of the other Transaction Documents or the consummation of the transactions described
herein or therein. The Company has furnished or made available to the Investor via EDGAR true and correct copies of the Company’s
Articles of Incorporation as in effect on the Closing Date (the “Charter”), and the Company’s
Bylaws as in effect on the Closing Date (the “Bylaws”).   

 

Section 5.4.        Intentionally
Left Blank.

 

    	9

    	 

    

  

Section 5.5.         
 No Conflicts.  The execution, delivery and performance by the Company of each of the Transaction Documents
to which it is a party and the consummation by the Company of the transactions contemplated hereby and thereby do not and shall
not (i) result in a violation of any provision of the Company’s Charter or Bylaws, (ii) conflict with or result in a breach
or violation of any of the terms or provisions of, or constitute a default (or an event which, with notice or lapse of time or
both, would become a default) under, or give rise to any rights of termination, amendment, acceleration or cancellation of, any
material agreement, mortgage, deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which
the Company or any of its Subsidiaries is a party or is bound, (iii) create or impose a lien, charge or encumbrance on any property
or assets of the Company or any of its Subsidiaries under any agreement or any commitment to which the Company or any of its Subsidiaries
is a party or by which the Company or any of its Subsidiaries is bound or to which any of their respective properties or assets
is subject, or (iv) result in a violation of any federal, state, local or foreign statute, rule, regulation, order, judgment or
decree applicable to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries
are bound or affected (including federal and state securities laws and regulations and the rules and regulations of the Trading
Market), except, in the case of clauses (ii), (iii) and (iv), for such conflicts, defaults, terminations, amendments, acceleration,
cancellations, liens, charges, encumbrances and violations as would not, individually or in the aggregate, have a Material Adverse
Effect.  Except as specifically contemplated by this Agreement or the Registration Rights Agreement and as required under
the Securities Act and any applicable state securities laws, the Company is not required under any federal, state, local or foreign
law, rule or regulation to obtain any consent, authorization or order of, or make any filing or registration with, any court or
governmental agency (including, without limitation, the Trading Market) in order for it to execute, deliver or perform any of
its obligations under the Transaction Documents to which it is a party, or to issue the Securities to the Investor in accordance
with the terms hereof and thereof (other than such consents, authorizations, orders, filings or registrations as have been obtained
or made prior to the Closing Date); provided, however, that, for purposes of the representation made in
this sentence, the Company is assuming and relying upon the accuracy of the representations and warranties of the Investor in
this Agreement and the compliance by it with its covenants and agreements contained in this Agreement and the Registration Rights
Agreement.

 

    	10

    	 

    

 

 

Section 5.6.Commission
Documents, Financial Statements.  (a)  The Company has timely filed (giving effect to permissible extensions
in accordance with Rule 12b-25 under the Exchange Act) all Commission Documents. The Company has delivered or made available to
the Investor via EDGAR or otherwise true and complete copies of the Commission Documents filed with or furnished to the Commission
prior to the Closing Date. No Subsidiary of the Company is required to file or furnish any report, schedule, registration, form,
statement, information or other document with the Commission. As of its filing date, each Commission Document filed with or furnished
to the Commission prior to the Closing Date complied in all material respects with the requirements of the Securities Act or the
Exchange Act, as applicable, and other federal, state and local laws, rules and regulations applicable to it, and, as of its filing
date (or, if amended or superseded by a filing prior to the Closing Date, on the date of such amended or superseded filing), such
Commission Document did not contain any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.
The Registration Statement, on the date it is filed with the Commission, on the date it is declared effective by the Commission
(or becomes effective pursuant to Section 8 of the Securities Act), on each Draw Down Exercise Date and on each Settlement Date,
shall comply in all material respects with the requirements of the Securities Act (including, without limitation, Rule 415 under
the Securities Act) and shall not contain any untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary in order to make the statements therein not misleading, except that this representation and warranty
shall not apply to statements in or omissions from the Registration Statement made in reliance upon and in conformity with information
relating to the Investor furnished to the Company in writing by or on behalf of the Investor expressly for use therein. The Prospectus
and each Prospectus Supplement required to be filed pursuant to this Agreement or the Registration Rights Agreement after the
Closing Date, when taken together, on its date, on each Draw Down Exercise Date and on each Settlement Date, shall comply in all
material respects with the requirements of the Securities Act (including, without limitation, Rule 424(b) under the Securities
Act) and shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading,
except that this representation and warranty shall not apply to statements in or omissions from the Prospectus or any Prospectus
Supplement made in reliance upon and in conformity with information relating to the Investor furnished to the Company in writing
by or on behalf of the Investor expressly for use therein. Each Commission Document (other than the Registration Statement, the
Prospectus or any Prospectus Supplement) to be filed with or furnished to the Commission after the Closing Date and incorporated
by reference in the Registration Statement, the Prospectus or any Prospectus Supplement required to be filed pursuant to this
Agreement or the Registration Rights Agreement (including, without limitation, the Current Report), when such document is filed
with or furnished to the Commission and, if applicable, when such document becomes effective, as the case may be, shall comply
in all material respects with the requirements of the Securities Act or the Exchange Act, as applicable, and other federal, state
and local laws, rules and regulations applicable to it, and shall not contain any untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. The Company has delivered or made available to the Investor via EDGAR or otherwise
true and complete copies of all comment letters and substantive correspondence received by the Company from the Commission relating
to the Commission Documents filed with or furnished to the Commission as of the Closing Date, together with all written responses
of the Company thereto in the form such responses were filed via EDGAR. There are no outstanding or unresolved comments or undertakings
in such comment letters received by the Company from the Commission. The Commission has not issued any stop order or other order
suspending the effectiveness of any registration statement filed by the Company under the Securities Act or the Exchange Act.

 

(b)               The
financial statements, together with the related notes and schedules, of the Company included in the Commission Documents comply
as to form in all material respects with all applicable accounting requirements and the published rules and regulations of the
Commission and all other applicable rules and regulations with respect thereto. Such financial statements, together with the related
notes and schedules, have been prepared in accordance with GAAP applied on a consistent basis during the periods involved (except
(i) as may be otherwise indicated in such financial statements or the notes thereto or (ii) in the case of unaudited interim statements,
to the extent they may not include footnotes or may be condensed or summary statements), and fairly present in all material respects
the financial condition of the Company and its consolidated Subsidiaries as of the dates thereof and the results of operations
and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments).

 

    	11

    	 

    

  

(c)                The
Company has timely filed with the Commission and made available to the Investor via EDGAR or otherwise all certifications and
statements required by (x) Rule 13a-14 or Rule 15d-14 under the Exchange Act or (y) 18 U.S.C. Section 1350 (Section 906 of the
Sarbanes-Oxley Act of 2002 (“SOXA”)) with respect to all relevant Commission Documents.  The Company
maintains disclosure controls and procedures required by Rule 13a-15 or Rule 15d-15 under the Exchange Act; Except as set forth
in the Commission Documents, such controls and procedures are effective to ensure that all material information concerning the
Company and its Subsidiaries is made known on a timely basis to the individuals responsible for the timely and accurate preparation
of the Company’s Commission filings and other public disclosure documents.  As used in this Section 5.6(c), the term
“file” shall be broadly construed to include any manner in which a document or information is furnished, supplied
or otherwise made available to the Commission.

 

(d)               HJ
& Associates, LLC, which shall express its opinion on the audited financial statements and related schedules to be included
or incorporated by reference in the Registration Statement and the Prospectus is, with respect to the Company, independent public
accountants as required by the Securities Act and is an independent registered public accounting firm within the meaning of SOXA
as required by the rules of the Public Company Accounting Oversight Board. HJ & Associates, LLC has not been engaged by the
Company to perform any “prohibited activities” (as defined in Section 10A of the Exchange Act).

 

Section 5.7.            Intentionally
left blank.

 

Section 5.8.         
 No Material Adverse Effect. Except as disclosed in any Commission Documents filed since November 13, 2014, since
November 13, 2014, the Company has not experienced or suffered any Material Adverse Effect, and there exists no current state
of facts, condition or event which would have a Material Adverse Effect.

 

Section 5.9.         
 No Undisclosed Liabilities. Except as set forth in the Commission Documents, neither the Company nor any of its
Subsidiaries has any liabilities, obligations, claims or losses (whether liquidated or unliquidated, secured or unsecured, absolute,
accrued, contingent or otherwise) that would be required to be disclosed on a balance sheet of the Company or any Subsidiary (including
the notes thereto) in conformity with GAAP and are not disclosed in the Commission Documents, other than those incurred in the
ordinary course of the Company’s or its Subsidiaries respective businesses since November 13, 2014 and which, individually
or in the aggregate, do not or would not have a Material Adverse Effect.

 

Section 5.10.     
 No Undisclosed Events or Circumstances. Except as set forth in the Commission Documents, no event or circumstance
has occurred or information exists with respect to the Company or any of its Subsidiaries or its or their business, properties,
liabilities, operations (including results thereof) or conditions (financial or otherwise), which, under applicable law, rule
or regulation, requires public disclosure or announcement by the Company at or before the Closing but which has not been so publicly
announced or disclosed, except for events or circumstances which, individually or in the aggregate, do not or would not have a
Material Adverse Effect.

 

    	12

    	 

    

 

Section 5.11.     
 Indebtedness; Solvency.  The Company’s Quarterly Report on Form 10-Q for its fiscal quarter ended
September 30, 2014 sets forth, as of September 30, 2014, all outstanding secured and unsecured Indebtedness of the Company or
any Subsidiary, or for which the Company or any Subsidiary has commitments through such date.  For the purposes of this Agreement,
“Indebtedness” shall mean (a) any liabilities for borrowed money or amounts owed in excess of $1,000
(other than trade accounts payable incurred in the ordinary course of business), (b) all guaranties, endorsements, indemnities
and other contingent obligations in respect of Indebtedness of others in excess of $1,000, whether or not the same are or should
be reflected in the Company’s balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments
for deposit or collection or similar transactions in the ordinary course of business; and (c) the present value of any lease payments
in excess of $1,000 due under leases required to be capitalized in accordance with GAAP.  There is no existing or continuing
default or event of default in respect of any Indebtedness of the Company or any of its Subsidiaries. The Company has not taken
any steps, and does not currently expect to take any steps, to seek protection pursuant to Title 11 of the United States Code
or any similar federal or state bankruptcy law or law for the relief of debtors, nor does the Company have any Knowledge that
its creditors intend to initiate involuntary bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings
for relief under Title 11 of the United States Code or any other federal or state bankruptcy law or any law for the relief of
debtors. The Company is financially solvent and is generally able to pay its debts as they become due.

 

Section 5.12.     
 Title To Assets.  Each of the Company and its Subsidiaries has good and valid title to, or has valid rights
to lease or otherwise use, all of their respective real and personal property reflected in the Commission Documents, free of mortgages,
pledges, charges, liens, security interests or other encumbrances, except for those indicated in the Commission Documents and
those that would not have a Material Adverse Effect. All real property and facilities held under lease by the Company or any of
its Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and
do not interfere with the use made and proposed to be made of such property and buildings by the Company or any of its Subsidiaries.

 

Section 5.13.     
 Actions Pending.  To the Knowledge of the Company, there is no action, suit, claim, investigation or proceeding
pending or threatened against the Company or any Subsidiary which questions the validity of the Transaction Documents or the transactions
contemplated thereby or any action taken or to be taken pursuant thereto.  Except as set forth in the Commission Documents,
to the Knowledge of the Company, there is no action, suit, claim, investigation or proceeding pending or threatened against or
involving the Company, any Subsidiary or any of their respective properties or assets, or involving any officers or directors
of the Company or any of its Subsidiaries, including, without limitation, any securities class action lawsuit or stockholder derivative
lawsuit related to the Company, in each case which, if determined adversely to the Company, its Subsidiary or any officer or director
of the Company or its Subsidiaries, would have a Material Adverse Effect. Except as set forth in the Commission Documents, no
judgment, order, writ, injunction or decree or award has been issued by or, to the Knowledge of the Company, requested of any
court, arbitrator or governmental agency which would be reasonably expected to result in a Material Adverse Effect.

 

    	13

    	 

    

 

Section 5.14.     
 Compliance With Law. The business of the Company and the Subsidiaries has been and is presently being conducted
in compliance with all applicable federal, state, local and foreign governmental laws, rules, regulations and ordinances, except
as set forth in the Commission Documents and except for such non-compliance which, individually or in the aggregate, would not
have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is in violation of any judgment, decree or order
or any statute, ordinance, rule or regulation applicable to the Company or any of its Subsidiaries, and neither the Company nor
any of its Subsidiaries will conduct its business in violation of any of the foregoing, except in all cases for possible violations
which could not, individually or in the aggregate, have a Material Adverse Effect. Without limiting the generality of the foregoing,
the Company has maintained all requirements for the continued listing or quotation of its Common Stock on the Trading Market,
and the Company is not in violation of any of the rules, regulations or requirements of the Trading Market and has no Knowledge
of any facts or circumstances that could reasonably lead to delisting or suspension of the Common Stock by the Trading Market
in the foreseeable future.

 

Section 5.15.     
 Certain Fees.  No brokers, finders or financial advisory fees or commissions are or shall be payable by
the Company or any Subsidiary (or any of their respective Affiliates) with respect to the transactions contemplated by the Transaction
Documents.

 

Section 5.16.     
 Disclosure.  The Company confirms that neither it nor any other Person acting on its behalf has provided
the Investor or any of its agents, advisors or counsel with any information that constitutes or could reasonably be expected to
constitute material, nonpublic information concerning the Company or any of its Subsidiaries, other than the existence of the
transactions contemplated by the Transaction Documents. The Company understands and confirms that the Investor will rely on the
foregoing representations in effecting transactions in securities of the Company. All disclosure provided to Investor regarding
the Company and its Subsidiaries, their businesses and the transactions contemplated by the Transaction Documents (including,
without limitation, the representations and warranties of the Company contained in the Transaction Documents to which it is a
party (as modified by the Disclosure Schedule)) furnished by or on behalf of the Company or any of its Subsidiaries, taken together,
is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary
in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. Each
press release issued by the Company or any of its Subsidiaries during the 12 months preceding the Closing Date did not at the
time of release (or, if amended or superseded by a later dated press release issued by the Company or any of its Subsidiaries
prior to the Closing Date or by a later dated Commission Document filed with or furnished to the Commission by the Company prior
to the Closing Date, at the time of issuance of such later dated press release or filing or furnishing of such Commission Document,
as applicable) contain any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they are made, not misleading.

 

    	14

    	 

    

 

Section 5.17.     
 Operation of Business.  (a)  The Company or one or more of its Subsidiaries possesses such permits,
licenses, approvals, consents and other authorizations (including licenses, accreditation and other similar documentation or approvals
of any local health departments) issued by the appropriate federal, state, local or foreign regulatory agencies or bodies as are
necessary to conduct the business now operated by it (collectively, “Governmental Licenses”), except
where the failure to possess such Governmental Licenses, individually or in the aggregate, would not have a Material Adverse Effect.
The Company and its Subsidiaries are in compliance with the terms and conditions of all such Governmental Licenses, except where
the failure to so comply, individually or in the aggregate, would not have a Material Adverse Effect or except as otherwise disclosed
in the Commission Documents.  All of the Governmental Licenses are valid and in full force and effect, except where the invalidity
of such Governmental Licenses or the failure of such Governmental Licenses to be in full force and effect, individually or in
the aggregate, would not have a Material Adverse Effect or except as otherwise disclosed in the Commission Documents.  Except
as set forth in the Commission Documents, neither the Company nor any of its Subsidiaries has received any written notice of proceedings
relating to the revocation or modification of any such Governmental Licenses which, if the subject of any unfavorable decision,
ruling or finding, individually or in the aggregate, would have a Material Adverse Effect. This Section 5.17 does not relate
to environmental matters, such items being the subject of Section 5.18.

 

(b)               The
Company or one or more of its Subsidiaries owns or possesses adequate patents, patent rights, licenses, inventions, copyrights,
know-how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or
procedures), trademarks, service marks, trade names, trade dress, logos, copyrights and other intellectual property, including,
without limitation, all of the intellectual property described in the Commission Documents as being owned or licensed by the Company
(collectively, “Intellectual Property”), necessary to carry on the business now operated by it. 
Except as set forth in the Commission Documents, there are no actions, suits or judicial proceedings pending, or to the Company’s
Knowledge threatened, relating to patents or proprietary information to which the Company or any of its Subsidiaries is a party
or of which any property of the Company or any of its Subsidiaries is subject, and neither the Company nor any of its Subsidiaries
has received any notice or is otherwise aware of any infringement of or conflict with asserted rights of others with respect to
any Intellectual Property or of any facts or circumstances which could render any Intellectual Property invalid or inadequate
to protect the interest of the Company and its Subsidiaries therein, and which infringement or conflict (if the subject of any
unfavorable decision, ruling or finding) or invalidity or inadequacy, individually or in the aggregate, would have a Material
Adverse Effect.

 

    	15

    	 

    

 

Section 5.18.     
 Environmental Compliance.  Except as disclosed in the Commission Documents, the Company and each of its
Subsidiaries have obtained all material approvals, authorization, certificates, consents, licenses, orders and permits or other
similar authorizations of all governmental authorities, or from any other person, that are required under any Environmental Laws,
except for any approvals, authorization, certificates, consents, licenses, orders and permits or other similar authorizations
the failure of which to obtain does not or would not have a Material Adverse Effect.  “Environmental Laws”
shall mean all applicable laws relating to the protection of the environment including, without limitation, all requirements pertaining
to reporting, licensing, permitting, controlling, investigating or remediating emissions, discharges, releases or threatened releases
of hazardous substances, chemical substances, pollutants, contaminants or toxic substances, materials or wastes, whether solid,
liquid or gaseous in nature, into the air, surface water, groundwater or land, or relating to the manufacture, processing, distribution,
use, treatment, storage, disposal, transport or handling of hazardous substances, chemical substances, pollutants, contaminants
or toxic substances, material or wastes, whether solid, liquid or gaseous in nature.  Except for such instances as would
not, individually or in the aggregate, have a Material Adverse Effect, to the Company’s Knowledge, there are no past or
present events, conditions, circumstances, incidents, actions or omissions relating to or in any way affecting the Company or
its Subsidiaries that violate or could reasonably be expected to violate any Environmental Law after the Closing Date or that
could reasonably be expected to give rise to any environmental liability, or otherwise form the basis of any claim, action, demand,
suit, proceeding, hearing, study or investigation (i) under any Environmental Law, or (ii) based on or related to the manufacture,
processing, distribution, use, treatment, storage (including without limitation underground storage tanks), disposal, transport
or handling, or the emission, discharge, release or threatened release of any hazardous substance.

 

Section 5.19.     
 Material Agreements.  Except as set forth in the Commission Documents, neither the Company nor any Subsidiary
of the Company is a party to any written or oral contract, instrument, agreement commitment, obligation, plan or arrangement,
a copy of which would be required to be filed with the Commission as an exhibit to an annual report on Form 10-K (collectively,
“Material Agreements”).  Except as set forth in the Commission Documents, the Company and each
of its Subsidiaries have performed in all material respects all the obligations then required to be performed by them under the
Material Agreements, have received no notice of default or an event of default by the Company or any of its Subsidiaries thereunder
and are not aware of any basis for the assertion thereof, and neither the Company or any of its Subsidiaries nor, to the Knowledge
of the Company, any other contracting party thereto are in default under any Material Agreement now in effect, the result of which
would have a Material Adverse Effect.  Except as set forth in the Commission Documents, each of the Material Agreements is
in full force and effect, and constitutes a legal, valid and binding obligation enforceable in accordance with its terms against
the Company and/or any of its Subsidiaries and, to the Knowledge of the Company, each other contracting party thereto, except
as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, conservatorship,
receivership or similar laws relating to, or affecting generally the enforcement of, creditor’s rights and remedies or by
other equitable principles of general application.

 

Section 5.20.     
 Transactions With Affiliates.  Except as set forth in the Commission Documents, there are no loans, leases,
agreements, contracts, royalty agreements, management contracts, service arrangements or other continuing transactions exceeding
$120,000 between (a) the Company or any Subsidiary, on the one hand, and (b) any person or entity who would be covered by Item
404(a) of Regulation S-K, on the other hand.  Except as disclosed in the Commission Documents, there are no outstanding amounts
payable to or receivable from, or advances by the Company or any of its Subsidiaries to, and neither the Company nor any of its
Subsidiaries is otherwise a creditor of or debtor to, any beneficial owner of more than 5% of the outstanding shares of Common
Stock, or any director, employee or affiliate of the Company or any of its Subsidiaries, other than (i) reimbursement for reasonable
expenses incurred on behalf of the Company or any of its Subsidiaries or (ii) as part of the normal and customary terms of such
person’s employment or service as a director with the Company or any of its Subsidiaries.

 

    	16

    	 

    

  

Section 5.21.     
 Employees.  Neither the Company nor any Subsidiary of the Company has any collective bargaining
arrangements or agreements covering any of its employees, except as set forth in the Commission Documents.  Except as disclosed
in the Commission Documents, no officer, consultant or key employee of the Company or any Subsidiary whose termination, either
individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect, has terminated or, to the Knowledge
of the Company, has any present intention of terminating his or her employment or engagement with the Company or any Subsidiary.

 

Section 5.22.     
 Use of Proceeds.  The proceeds from the sale of the Shares shall be used by the Company and its Subsidiaries
as set forth in the Prospectus and any Prospectus Supplement filed pursuant to Section 2.3 of this Agreement and pursuant to the
Registration Rights Agreement.

 

Section 5.23.     
 Investment Company Act Status.  The Company is not, and as a result of the consummation of the transactions
contemplated by the Transaction Documents and the application of the proceeds from the sale of the Shares as set forth in the
Prospectus and any Prospectus Supplement shall not be required to be registered as, an “investment company” or a company
“controlled” by an “investment company,” within the meaning of the Investment Company Act of 1940, as
amended.

 

Section 5.24.     
 ERISA.  No liability to the Pension Benefit Guaranty Corporation has been incurred with respect to any Plan
by the Company or any of its Subsidiaries which has had or would have a Material Adverse Effect.  No “prohibited transaction”
(as defined in Section 406 of ERISA or Section 4975 of the Code) or “accumulated funding deficiency” (as defined in
Section 302 of ERISA) or any of the events set forth in Section 4043(b) of ERISA has occurred with respect to any Plan which has
had or would have a Material Adverse Effect, and the execution and delivery of this Agreement and the issuance and sale of the
Securities hereunder shall not result in any of the foregoing events.  Each Plan is in compliance in all material respects
with applicable law, including ERISA and the Code; the Company has not incurred and does not expect to incur liability under Title
IV of ERISA with respect to the termination of, or withdrawal from, any Plan; and each Plan for which the Company would have any
liability that is intended to be qualified under Section 401(a) of the Code is so qualified in all material respects and nothing
has occurred, whether by action or failure to act, which would cause the loss of such qualifications.  As used in this Section
5.24, the term “Plan” shall mean an “employee pension benefit plan” (as defined in Section
3 of ERISA) which is or has been established or maintained, or to which contributions are or have been made, by the Company or
any Subsidiary or by any trade or business, whether or not incorporated, which, together with the Company or any Subsidiary, is
under common control, as described in Section 414(b) or (c) of the Code.

 

    	17

    	 

    

 

Section 5.25.     
 Taxes.  The Company and each of its Subsidiaries (i) has filed all necessary federal, state and foreign
income and franchise tax returns or has duly requested extensions thereof, except for those the failure of which to file would
not have a Material Adverse Effect, (ii) has paid all federal, state, local and foreign taxes due and payable for which it is
liable, except to the extent that any such taxes are being contested in good faith and by appropriate proceedings, except for
such taxes the failure of which to pay would not have a Material Adverse Effect, and (iii) does not have any tax deficiency or
claims outstanding or assessed or, to the Company’s Knowledge, proposed against it which would have a Material Adverse Effect.
There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers
of the Company and its Subsidiaries know of no basis for any such claim. The Company is not operated in such a manner as to qualify
as a passive foreign investment company, as defined in Section 1297 of the Code.

 

Section 5.26.     
 Insurance. The Company and its Subsidiaries are insured by insurers of recognized financial responsibility against
such losses and risks and in such amounts as management of the Company believes to be prudent and customary in the businesses
in which the Company and its Subsidiaries are engaged. Neither the Company nor any such Subsidiary has been refused any insurance
coverage sought or applied for, and neither the Company nor any such Subsidiary has any reason to believe that it will be unable
to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers
as may be necessary to continue its business at a cost that would not have a Material Adverse Effect.

 

Section 5.27.     
 U.S. Real Property Holding Corporation. Neither the Company nor any of its Subsidiaries is, or has ever been,
and so long as any of the Securities are held by the Investor, shall become a U.S. real property holding corporation within the
meaning of Section 897 of the Code.

 

Section 5.28.     
 Valid Issuances. At the request of and with the express agreement of the Investor, the Shares will be delivered
to the Investor via book entry through DTC and will not bear legends noting restrictions as to resale of such securities under
federal or state securities laws, nor will any such securities be subject to stop transfer instructions. Neither the offer or
sale of the Securities pursuant to, nor the Company’s performance of its obligations under, the Transaction Documents to
which it is a party shall (i) result in the creation or imposition of any liens, charges, claims or other encumbrances upon the
Securities, or (ii) entitle the holders of any outstanding shares of capital stock of the Company to preemptive or other
rights to subscribe to or acquire the shares of Common Stock or other securities of the Company.

 

Section 5.29.     
 No General Solicitation or Advertising. Neither the Company, nor any of its Subsidiaries or Affiliates, nor any
Person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning
of Regulation D) in connection with the offer or sale of the Securities.

 

Section 5.30.     
 No Integrated Offering. None of the Company, its Subsidiaries or any of their Affiliates, nor any Person acting
on their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security,
under circumstances that would require registration of the issuance of any of the Securities under the Securities Act, whether
through integration with prior offerings or otherwise, or cause this offering of the Securities to require approval of stockholders
of the Company under any applicable stockholder approval provisions, including, without limitation, under the rules and regulations
of the Trading Market.  None of the Company, its Subsidiaries, their Affiliates nor any Person acting on their behalf will
take any action or steps referred to in the preceding sentence that would require registration of the issuance of any of the Securities
under the Securities Act or cause the offering of any of the Securities to be integrated with other offerings.

 

    	18

    	 

    

 

Section 5.31.     
 Dilutive Effect. The Company is aware and acknowledges that issuance of the Securities could cause dilution to
existing stockholders and could significantly increase the outstanding number of shares of Common Stock.

 

Section 5.32.     
 Manipulation of Price.  Neither the Company nor any of its officers, directors or Affiliates has, and, to
the Knowledge of the Company, no Person acting on their behalf has, (i) taken, directly or indirectly, any action designed or
intended to cause or to result in the stabilization or manipulation of the price of any security of the Company, or which caused
or resulted in, or which would in the future reasonably be expected to cause or result in, the stabilization or manipulation of
the price of any security of the Company, in each case to facilitate the sale or resale of any of the Securities, or (ii) sold,
bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities. Neither the Company nor any of
its officers, directors or Affiliates will during the term of this Agreement, and, to the Knowledge of the Company, no Person
acting on their behalf will during the term of this Agreement, take any of the actions referred to in the immediately preceding
sentence.

 

Section 5.33.     
 Securities Act. The Company has complied and shall comply with all applicable federal and state securities laws
in connection with the offer, issuance and sale of the Securities hereunder, including, without limitation, the applicable requirements
of the Securities Act. The Registration Statement, upon filing with the Commission and at the time it is declared effective by
the Commission (or becomes effective pursuant to Section 8 of the Securities Act), shall satisfy all of the requirements of the
Securities Act to register the resale of the Registrable Securities by the Investor in accordance with the Registration Rights
Agreement on a delayed or continuous basis under Rule 415 under the Securities Act at then-prevailing market prices, and not fixed
prices. The Company is not an issuer identified in Rule 144(i).

 

Section 5.34.     
 Listing and Maintenance Requirements. The Company’s Common Stock is registered pursuant to Section 12(g)
of the Exchange Act, and the Company has taken no action designed to, or which to its Knowledge is likely to have the effect of,
terminating the registration of the Common Stock under the Exchange Act, nor has the Company received any notification that the
Commission is contemplating terminating such registration. The Company has not, in the 12 months preceding the Closing Date, received
notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not
in compliance with the listing or maintenance requirements of such Trading Market. As of the Closing Date, the Company is in compliance
with all such listing and maintenance requirements.

 

Section 5.35.     
 Application of Takeover Protections. The Company and its Board of Directors have taken all necessary action,
if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or other similar anti-takeover provision under the Company’s Charter or the laws of its state
of incorporation that is or could become applicable to the Investor as a result of the Investor and the Company fulfilling their
respective obligations or exercising their respective rights under the Transaction Documents (as applicable), including, without
limitation, as a result of the Company’s issuance of the Securities and the Investor’s ownership of the Securities.

 

    	19

    	 

    

 

Section 5.36.     
 Foreign Corrupt Practices Act.  None of the Company, any Subsidiary or, to the Knowledge of the Company,
any director, officer, agent, employee, affiliate or other Person acting on behalf of the Company or any of its Subsidiaries,
is aware of or has taken any action, directly or indirectly, that would result in a violation by such Persons of the Foreign Corrupt
Practices Act of 1977, as amended, and the rules and regulations thereunder (collectively, the “FCPA”),
including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance
of an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or
authorization of the giving of anything of value to any “foreign official” (as such term is defined in the FCPA) or
any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA. 
The Company and the Subsidiaries have conducted their respective businesses in compliance with the FCPA.

 

Section 5.37.     
 Money Laundering Laws.  The operations of the Company and its Subsidiaries are and have been conducted at
all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions
Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and
any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively,
the “Money Laundering Laws”) and, to the Knowledge of the Company, no action, suit or proceeding by
or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its Subsidiaries
with respect to the Money Laundering Laws is pending or threatened. 

 

Section 5.38.     
 OFAC.  None of the Company, any Subsidiary or, to the Knowledge of the Company, any director, officer, agent,
employee, affiliate or Person acting on behalf of the Company or any of its Subsidiaries is currently subject to any U.S. sanctions
administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the
Company will not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise make available such
proceeds to any subsidiary, joint venture partner or other Person, for the purpose of financing the activities of any Person currently
subject to any U.S. sanctions administered by OFAC.

 

Section 5.39.      Intentionally
Left Blank.

 

Section 5.40.      Intentionally
Left Blank

 

Section 5.41.     
 Acknowledgement Regarding Investor’s Acquisition of Securities. The Company acknowledges and agrees that
the Investor is acting solely in the capacity of an arm’s length purchaser with respect to this Agreement and the transactions
contemplated by the Transaction Documents. The Company further acknowledges that the Investor is not acting as a financial advisor
or fiduciary of the Company (or in any similar capacity) with respect to this Agreement and the transactions contemplated by the
Transaction Documents, and any advice given by the Investor or any of its representatives or agents in connection therewith is
merely incidental to the Investor’s acquisition of the Securities. The Company further represents to the Investor that the
Company’s decision to enter into the Transaction Documents to which it is a party has been based solely on the independent
evaluation of the transactions contemplated thereby by the Company and its representatives. The Company acknowledges and agrees
that the Investor has not made and does not make any representations or warranties with respect to the transactions contemplated
by the Transaction Documents other than those specifically set forth in Article IV of this Agreement.  

 

    	20

    	 

    

 

ARTICLE
VI

ADDITIONAL COVENANTS

 

The Company covenants
with the Investor, and the Investor covenants with the Company, as follows, which covenants of one party are for the benefit of
the other party, during the Investment Period:

 

Section 6.1.         
 Securities Compliance. The Company shall notify the Commission and the Trading Market, if and as applicable,
in accordance with their respective rules and regulations, of the transactions contemplated by the Transaction Documents, and
shall take all necessary action, undertake all proceedings and obtain all registrations, permits, consents and approvals for the
legal and valid issuance of the Securities to the Investor in accordance with the terms of the Transaction Documents, as applicable.

 

Section 6.2.         
 Reservation of Common Stock. The Company has available and the Company shall reserve and keep available at all
times, free of preemptive and other similar rights of stockholders, the requisite aggregate number of authorized but unissued
shares of Common Stock to enable the Company to timely effect the issuance, sale and delivery in full to the Investor of all Securities
to be issued and delivered under this Agreement, in any case prior to the issuance to the Investor of such Securities. The number
of shares of Common Stock so reserved from time to time, as theretofore increased or reduced as hereinafter provided, may be reduced
by the number of shares of Common Stock actually delivered pursuant to this Agreement.

 

Section 6.3.         
 Registration and Listing.  The Company shall take all action necessary to cause the Common Stock to continue
to be registered as a class of securities under Sections 12(g) of the Exchange Act, shall comply with its reporting and filing
obligations under the Exchange Act, and shall not take any action or file any document (whether or not permitted by the Securities
Act or the Exchange Act) to terminate or suspend such registration or to terminate or suspend its reporting and filing obligations
under the Exchange Act or Securities Act, except as permitted herein. The Company shall use its reasonable best efforts to continue
the listing and trading of its Common Stock and the listing of the Securities purchased or acquired by the Investor hereunder
on the Trading Market and to comply with the Company’s reporting, filing and other obligations under the bylaws, listed
securities maintenance standards and other rules and regulations of the Trading Market. The Company shall not take any action
which could be reasonably expected to result in the delisting or suspension of the Common Stock on the Trading Market. If the
Company receives any final and non-appealable notice that the listing or quotation of the Common Stock on the Trading Market shall
be terminated on a date certain, the Company shall promptly (and in any case within 48 hours) notify the Investor of such fact
in writing and shall use its reasonable best efforts to cause the Common Stock to be listed or quoted on another Trading Market
prior to such date certain. The Company shall use its reasonable best efforts to continue the quotation and trading of its Common
Stock and the quotation of the Securities purchased or acquired by the Investor hereunder on the OTCQB, including (i) undertaking
a reverse stock split when required in order to regain compliance with OTCQB’s minimum bid price requirement, (ii) paying
the applicable fee, and (iii) providing the required OTCQB certifications.

 

    	21

    	 

    

 

Section 6.4.          Compliance
with Laws.

 

(i)              The
Company shall comply, and cause each Subsidiary to comply, (a) with all laws, rules, regulations and orders applicable to the
business and operations of the Company and its Subsidiaries, except as would not have a Material Adverse Effect and (b) with all
applicable provisions of the Securities Act and the Exchange Act and the rules and regulations of the Trading Market. Without
limiting the foregoing, neither the Company, nor any of its Subsidiaries, nor to the Knowledge of the Company, any of their respective
directors, officers, agents, employees or any other Persons acting on their behalf shall, in connection with the operation of
the Company’s and its Subsidiaries’ respective businesses, (1) use any corporate funds for unlawful contributions,
payments, gifts or entertainment or to make any unlawful expenditures relating to political activity to government officials,
candidates or members of political parties or organizations, (2) pay, accept or receive any unlawful contributions, payments,
expenditures or gifts, or (3) violate or operate in noncompliance with any export restrictions, anti-boycott regulations, embargo
regulations or other applicable domestic or foreign laws and regulations, including, without limitation, the FCPA and the Money
Laundering Laws.

 

(ii)          The
Investor shall comply with all laws, rules, regulations and orders applicable to the performance by it of its obligations under
this Agreement and its investment in the Securities, except as would not, individually or in the aggregate, prohibit or otherwise
interfere with the ability of the Investor to enter into and perform its obligations under this Agreement in any material respect.
Without limiting the foregoing, the Investor shall comply with all applicable provisions of the Securities Act and the Exchange
Act, including Regulation M thereunder, and any applicable securities laws of any non-U.S. jurisdictions.

 

Section 6.5.          Keeping
of Records and Books of Account; Due Diligence.

 

(i)The Company
shall keep and cause each Subsidiary to keep adequate records and books of account, in which complete entries shall be made in
accordance with GAAP consistently applied, reflecting all financial transactions of the Company and its Subsidiaries, and in which,
for each fiscal year, all proper reserves for depreciation, depletion, obsolescence, amortization, taxes, bad debts and other
purposes in connection with its business shall be made.  The Company shall maintain a system of internal accounting controls
that (a) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions
of the assets of the Company; (b) provide reasonable assurance that transactions are recorded as necessary to permit preparation
of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the
Company are being made only in accordance with authorizations of management and directors of the Company; and (c) provide reasonable
assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets
that could have a material effect on the Company’s financial statements (it being acknowledged and agreed that the identification
by the Company and/or its independent registered public accounting firm of any “significant deficiencies” or “material
weaknesses” (each as defined by the Public Company Accounting Oversight Board) in the Company’s internal controls
over its financial reporting shall not, in and of itself, constitute a breach of this Section 6.5(i)).

 

    	22

    	 

    

 

(ii)               Subject
to the requirements of Section 6.16 of this Agreement, from time to time from and after the Closing Date, the Company shall
make available for inspection and review by the Investor during normal business hours and after reasonable notice, customary documentation
reasonably requested by the Investor and/or its appointed counsel or advisors to conduct due diligence; provided, however,
that after the Closing Date, the Investor’s continued due diligence shall not be a condition to the issuance of any Draw
Down Notice or the settlement of any Draw Down.

 

Section 6.6.         
 Limitations on Holdings and Issuances.  The Company shall not be obligated to issue and the Investor shall
not be obligated to purchase any shares of Common Stock which would cause the aggregate number of shares of Common Stock then
beneficially owned (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder) by the
Investor and its Affiliates to exceed the Ownership Limitation. Promptly following any request by the Company, the Investor shall
inform the Company of the number of shares of Common Stock then beneficially owned by the Investor and its Affiliates.

 

Section 6.7.          Other
Agreements. The Company shall not enter into, announce or recommend to its stockholders any agreement, plan,
arrangement or transaction in or of which the terms thereof would restrict, materially delay, conflict with or impair the ability
or right of the Company to perform its obligations under the Transaction Documents to which it is a party, including, without
limitation, the obligation of the Company to deliver the Shares to the Investor in respect of a Draw Down on the applicable Settlement
Date. For the avoidance of doubt, nothing in this Section 6.7 shall in any way limit the Company’s right to terminate this
Agreement in accordance with Section 8.1 (subject in all cases to Section 8.3).

 

Section 6.8.         
 Corporate Existence.  The Company shall take all steps necessary to preserve and continue the corporate
existence of the Company. For the avoidance of doubt, nothing in this Section 6.8 shall in any way limit the Company’s
right to terminate this Agreement in accordance with Section 8.1 (subject in all cases to Section 8.3).

 

Section 6.9.         
 Prohibited Transactions. Except as related to the transactions described herein, during the term of this Agreement,
the Company shall not enter into any Prohibited Transaction without the prior written consent of the Investor, which consent may
be withheld at the sole discretion of the Investor. For the purposes of this Agreement, the term “Prohibited Transaction”
shall refer to the issuance by the Company of any “future priced securities,” which shall mean the issuance of shares
of Common Stock or securities of any type whatsoever that are, or may become, convertible or exchangeable into shares of Common
Stock pursuant to any equity line financing registered under the Securities Act to anyone other than the Investor. For clarification
purposes, the transactions contemplated herein are not considered Prohibited Transactions.

 

    	23

    	 

    

  

Section 6.10.     
 Delivery of Registration Statement and Prospectus; Subsequent Changes. In accordance with the Registration Rights
Agreement, the Company shall deliver or make available to the Investor and its counsel, without charge, an electronic copy of
the Registration Statement, the Prospectus and all amendments and supplements to the Registration Statement or Prospectus that
are filed with the Commission during any period in which a Prospectus (or in lieu thereof, the notice referred to in Rule 173(a)
under the Securities Act) is required by the Securities Act to be delivered in connection with resales of the Registrable Securities,
in each case as soon as reasonably practicable after the filing thereof with the Commission. The Company shall provide the Investor
a reasonable opportunity to comment on a draft of each such document and shall give due consideration to all such comments. The
Company consents to the use of the Prospectus (and of any Prospectus Supplement thereto) in accordance with the provisions of
the Securities Act and with the securities or “Blue Sky” laws of the jurisdictions in which the Registrable Securities
may be sold by the Investor, in connection with the resale of the Registrable Securities and for such period of time thereafter
as the Prospectus (or in lieu thereof, the notice referred to in Rule 173(a) under the Securities Act) is required by the Securities
Act to be delivered in connection with resales of the Registrable Securities. If during such period of time any event shall occur
that in the reasonable judgment of the Company and its counsel is required to be set forth in the Registration Statement, the
Prospectus or any Prospectus Supplement or should be set forth therein in order to make the statements made therein (in the case
of the Prospectus or any Prospectus Supplement, in light of the circumstances under which they were made) not misleading, or if
it is necessary to amend the Registration Statement or supplement or amend the Prospectus or any Prospectus Supplement to comply
with the Securities Act or any other applicable law or regulation, the Company shall forthwith (i) notify the Investor to suspend
the resale of Registrable Securities during such period and (ii) prepare and file with the Commission an appropriate amendment
to the Registration Statement or Prospectus Supplement to the Prospectus, and shall expeditiously furnish or make available to
the Investor an electronic copy thereof, so as to correct such statement or omission or effect such compliance.

 

Section 6.11.     
 Amendments to the Registration Statement; Prospectus Supplements. Except as provided in this Agreement and other
than periodic reports required to be filed pursuant to the Exchange Act, the Company shall not file with the Commission any amendment
to the Registration Statement that relates to the Investor, the Transaction Documents or the transactions contemplated thereby
or file with the Commission any Prospectus Supplement that relates to the Investor, the Transaction Documents or the transactions
contemplated thereby with respect to which (a) the Investor shall not previously have been advised, (b) the Company shall not
have given due consideration to any comments thereon received from the Investor or its counsel, or (c) the Investor shall reasonably
object after being so advised, unless it is necessary to amend the Registration Statement or make any supplement to the Prospectus
to comply with the Securities Act or any other applicable law or regulation, in which case the Company shall promptly so inform
the Investor, the Investor shall be provided with a reasonable opportunity to review and comment upon any disclosure relating
to the Investor and the Company shall expeditiously furnish to the Investor an electronic copy thereof. In addition, for so long
as, in the reasonable opinion of counsel for the Investor, the Prospectus (or in lieu thereof, the notice referred to in Rule
173(a) under the Securities Act) is required to be delivered in connection with any sales of Registrable Securities by the Investor,
the Company shall not file any Prospectus Supplement without delivering or making available a copy of such Prospectus Supplement
to the Investor promptly. Upon receipt of amendment to the Registration Statement or Prospectus Supplement from the Company or
its counsel, the Investor shall promptly review such document and provide comments to the Company or its counsel regarding such
document, if any, within a reasonable period of time.

 

    	24

    	 

    

  

Section 6.12.     
 Stop Orders.  The Company shall notify the Investor as soon as possible (but in no event later than 24 hours),
and confirm in writing, upon its becoming aware of the occurrence of any of the following events in respect of the Registration
Statement or related Prospectus or Prospectus Supplement relating to an offering of Registrable Securities: (i) receipt of any
request by the Commission or any other federal or state governmental authority for any additional information relating to the
Registration Statement, the Prospectus or any Prospectus Supplement, or for any amendment of or supplement to the Registration
Statement, the Prospectus, or any Prospectus Supplement; (ii) the issuance by the Commission or any other federal or state governmental
authority of any stop order suspending the effectiveness of the Registration Statement or prohibiting or suspending the use of
the Prospectus or any Prospectus Supplement, or of the suspension of qualification or exemption from qualification of the Securities
for offering or sale in any jurisdiction, or the initiation or contemplated initiation of any proceeding for such purpose; and
(iii) any event or the existence of any condition or state of facts, which makes any statement of a material fact made in the
Registration Statement, the Prospectus or any Prospectus Supplement untrue or which requires the making of any additions to or
changes to the statements then made in the Registration Statement, the Prospectus or any Prospectus Supplement in order to state
a material fact required by the Securities Act to be stated therein or necessary in order to make the statements then made therein
(in the case of the Prospectus or any Prospectus Supplement, in light of the circumstances under which they were made) not misleading,
or which requires an amendment to the Registration Statement or a supplement to the Prospectus or any Prospectus Supplement to
comply with the Securities Act or any other law (other than the transactions contemplated by any Draw Down Notice and the settlement
thereof). The Company shall not be required to disclose to the Investor the substance or specific reasons of any of the events
set forth in clauses (i) through (iii) of the immediately preceding sentence, but rather, shall only be required to disclose that
the event has occurred.  The Company shall not issue any Draw Down during the continuation of any of the foregoing events.
If at any time the Commission or any other federal or state governmental authority shall issue any stop order suspending the effectiveness
of the Registration Statement or prohibiting or suspending the use of the Prospectus or any Prospectus Supplement, the Company
shall use commercially reasonable efforts to obtain the withdrawal of such order at the earliest possible time.

 

Section 6.13.      Selling
Restrictions. 

 

(i)               Except
as expressly set forth below, the Investor covenants that from and after the Closing Date through and including the Trading Day
next following the expiration or termination of this Agreement, neither the Investor nor any of its Affiliates nor any entity
managed or controlled by the Investor shall, directly or indirectly maintain a net short position in the Company’s Common
Stock.

 

    	25

    	 

    

 

(ii)               In
addition to the foregoing, in connection with any sale of Securities (including any sale permitted by paragraph (i) above), the
Investor shall comply in all respects with all applicable laws, rules, regulations and orders, including, without limitation,
the requirements of the Securities Act and the Exchange Act.

 

Section 6.14.     
 Effective Registration Statement.  During the Investment Period, the Company shall use its best efforts
to maintain the continuous effectiveness of the Registration Statement under the Securities Act.

 

Section 6.15.     
 Blue Sky.  The Company shall take such action, if any, as is necessary in order to obtain an exemption for
or to qualify the Securities for issuance and sale to the Investor pursuant to the Transaction Documents, at the request of the
Investor, and the subsequent resale of Registrable Securities by the Investor, in each case, under applicable state securities
or “Blue Sky” laws and shall provide evidence of any such action so taken to the Investor from time to time following
the Closing Date; provided, however, that the Company shall not be required in connection therewith or
as a condition thereto to (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but
for this Section 6.15, (y) subject itself to general taxation in any such jurisdiction, or (z) file a general consent to
service of process in any such jurisdiction.

 

Section 6.16.     
 Non-Public Information.  Neither the Company or any of its Subsidiaries, nor any of their respective directors,
officers, employees or agents shall disclose any material non-public information about the Company to the Investor, unless a simultaneous
public announcement thereof is made by the Company in the manner contemplated by Regulation FD. In the event of a breach of the
foregoing covenant by the Company or any of its Subsidiaries, or any of their respective directors, officers, employees and agents
(as determined in the reasonable good faith judgment of the Investor), (i) the Investor shall promptly provide written notice
of such breach to the Company and (ii) after such notice has been provided to the Company and in addition to any other remedy
provided herein or in the other Transaction Documents, the Investor shall have the right to make a public disclosure, in the form
of a press release, public advertisement or otherwise, of such material, non-public information without the prior approval by
the Company, any of its Subsidiaries, or any of their respective directors, officers, employees or agents; provided that the Company
shall have failed to publicly disclose such material, non-public information within 24 hours following demand therefor by the
Investor. The Investor shall not have any liability to the Company, any of its Subsidiaries, or any of their respective directors,
officers, employees, stockholders or agents, for any such disclosure.

 

Section 6.17.     
 Broker/Dealer.  The Investor shall use one or more broker-dealers to effectuate all sales, if any, of Securities
that it may purchase or otherwise acquire from the Company pursuant to the Transaction Documents, as applicable, which (or whom)
shall be unaffiliated with the Investor and not then currently engaged or used by the Company (collectively, the “Broker-Dealer”).
The Investor shall, from time to time, provide the Company with all information regarding the Broker-Dealer reasonably requested
by the Company. The Investor shall be solely responsible for all fees and commissions of the Broker-Dealer, which shall not exceed
customary brokerage fees and commissions.

 

    	26

    	 

    

  

Section 6.18.      Disclosure
Schedule.

 

(i)           The
Company may, from time to time, update the Disclosure Schedule as may be required to satisfy the condition set forth in Section
7.2(i).  For purposes of this Section 6.18, any disclosure made in a schedule to the Certificate substantially
in the form attached hereto as Exhibit C shall be deemed to be an update of the Disclosure Schedule. Notwithstanding
anything in this Agreement to the contrary, no update to the Disclosure Schedule pursuant to this Section 6.18 shall cure
any breach of a representation or warranty of the Company contained in this Agreement and made prior to the update and shall not
affect any of the Investor’s rights or remedies with respect thereto.

 

(ii)          Notwithstanding
anything to the contrary contained in the Disclosure Schedule or in this Agreement, the information and disclosure contained in
any Schedule of the Disclosure Schedule shall be deemed to be disclosed and incorporated by reference in any other Schedule of
the Disclosure Schedule as though fully set forth in such Schedule for which applicability of such information and disclosure
is readily apparent on its face.  The fact that any item of information is disclosed in the Disclosure Schedule shall not
be construed to mean that such information is required to be disclosed by this Agreement.  Except as expressly set forth
in this Agreement, such information and the thresholds (whether based on quantity, qualitative characterization, dollar amounts
or otherwise) set forth herein shall not be used as a basis for interpreting the terms “material” or “Material
Adverse Effect” or other similar terms in this Agreement. 

 

ARTICLE
VII

CONDITIONS TO CLOSING AND CONDITIONS TO THE SALE AND

PURCHASE OF THE SHARES

 

Section 7.1.         Conditions
Precedent to Closing. The Closing is subject to the satisfaction of each of the conditions set forth in this Section
7.1.

 

(i)            Accuracy
of the Investor’s Representations and Warranties.  The representations and warranties of the Investor contained
in this Agreement (a) that are not qualified by “materiality” shall be true and correct in all material respects as
of the Closing Date, except to the extent such representations and warranties are as of another date, in which case, such representations
and warranties shall be true and correct in all material respects as of such other date and (b) that are qualified by “materiality”
shall be true and correct as of the Closing Date, except to the extent such representations and warranties are as of another date,
in which case, such representations and warranties shall be true and correct as of such other date.

 

(ii)           Accuracy
of the Company’s Representations and Warranties.  The representations and warranties of the Company contained
in this Agreement (a) that are not qualified by “materiality” or “Material Adverse Effect” shall be true
and correct in all material respects as of the Closing Date, except to the extent such representations and warranties are as of
another date, in which case, such representations and warranties shall be true and correct in all material respects as of such
other date and (b) that are qualified by “materiality” or “Material Adverse Effect” shall be true
and correct as of the Closing Date, except to the extent such representations and warranties are as of another date, in which
case, such representations and warranties shall be true and correct as of such other date.

 

    	27

    	 

    

 

(iii)          Intentionally
Left Blank.

 

(iv)          Closing
Deliverables. At the Closing, counterpart signature pages of this Agreement, the Registration Rights Agreement and Escrow
Agreement executed by each of the parties thereto shall be delivered as provided in Section 2.2. Simultaneously with the
execution and delivery of this Agreement, the Registration Rights Agreement and the Escrow Agreement, the Investor’s counsel
shall have received a Closing Certificate from the Company, dated the Closing Date, in the form of Exhibit C hereto.

 

 Section 7.2.  Conditions
Precedent to a Draw Down. The right of the Company to deliver a Draw Down Notice and the obligation of the Investor to
accept a Draw Down Notice and to acquire and pay for the Shares in accordance therewith is subject to the satisfaction, at each
Draw Down Exercise Date and at each Settlement Date (except as otherwise expressly set forth below), of each of the conditions
set forth in this Section 7.2.

 

(i)            Accuracy
of the Company’s Representations and Warranties.  The representations and warranties of the Company contained
in this Agreement (a) that are not qualified by “materiality” or “Material Adverse Effect” shall have
been true and correct in all material respects when made and shall be true and correct in all material respects as of the applicable
Draw Down Exercise Date and the applicable Settlement Date with the same force and effect as if made on such dates, except to
the extent such representations and warranties are as of another date, in which case, such representations and warranties shall
be true and correct in all material respects as of such other date and (b) that are qualified by “materiality”
or “Material Adverse Effect” shall have been true and correct when made and shall be true and correct as of the applicable
Draw Down Exercise Date and the applicable Settlement Date with the same force and effect as if made on such dates, except to
the extent such representations and warranties are as of another date, in which case, such representations and warranties shall
be true and correct as of such other date. 

 

(ii)           Performance
of the Company.  The Company shall have performed, satisfied and complied in all material respects with all covenants,
agreements and conditions required by this Agreement and the Registration Rights Agreement to be performed, satisfied or complied
with by the Company at or prior to the applicable Draw Down Exercise Date and the applicable Settlement Date. The Company shall
have delivered to the Investor on the applicable Settlement Date the Compliance Certificate substantially in the form attached
hereto as Exhibit D. 

 

(iii)          Registration
Statement Effective. The Registration Statement covering the resale by the Investor of the Registrable Securities shall
have been declared effective under the Securities Act by the Commission or shall have become effective pursuant to Section 8 of
the Securities Act and shall remain effective, and the Investor shall be permitted to utilize the Prospectus therein to resell
(a) all of the Shares issued pursuant to all prior Draw Down Notices, and (b) all of the Shares issuable pursuant to the applicable
Draw Down Notice.

 

    	28

    	 

    

 

(iv)             No
Material Notices. None of the following events shall have occurred and be continuing: (a) receipt of any request by the
Commission or any other federal or state governmental authority for any additional information relating to the Registration Statement,
the Prospectus or any Prospectus Supplement, or for any amendment of or supplement to the Registration Statement, the Prospectus,
or any Prospectus Supplement; (b) the issuance by the Commission or any other federal or state governmental authority of any stop
order suspending the effectiveness of the Registration Statement or prohibiting or suspending the use of the Prospectus or any
Prospectus Supplement, or of the suspension of qualification or exemption from qualification of the Securities for offering or
sale in any jurisdiction, or the initiation or contemplated initiation of any proceeding for such purpose; or (c) the occurrence
of any event or the existence of any condition or state of facts, which makes any statement of a material fact made in the Registration
Statement, the Prospectus or any Prospectus Supplement untrue or which requires the making of any additions to or changes to the
statements then made in the Registration Statement, the Prospectus or any Prospectus Supplement in order to state a material fact
required by the Securities Act to be stated therein or necessary in order to make the statements then made therein (in the case
of the Prospectus or any Prospectus Supplement, in light of the circumstances under which they were made) not misleading, or which
requires an amendment to the Registration Statement or a supplement to the Prospectus or any Prospectus Supplement to comply with
the Securities Act or any other law (other than the transactions contemplated by the applicable Draw Down Notice and the settlement
thereof). The Company shall have no Knowledge of any event that could reasonably be expected to have the effect of causing the
suspension of the effectiveness of the Registration Statement or the prohibition or suspension of the use of the Prospectus or
any Prospectus Supplement in connection with the resale of the Registrable Securities by the Investor.

 

(v)               Other
Commission Filings. The Current Report shall have been filed with the Commission as required pursuant to Section 2.3,
and the final Prospectus and all other Prospectus Supplements required to have been filed with the Commission pursuant to Section
2.3 and pursuant to the Registration Rights Agreement shall have been filed with the Commission in accordance with Section
2.3 and the Registration Rights Agreement. All reports, schedules, registrations, forms, statements, information and other
documents required to have been filed by the Company with the Commission pursuant to the reporting requirements of the Exchange
Act, including all material required to have been filed pursuant to Section 13(a) or 15(d) of the Exchange Act, shall have been
filed with the Commission and, if any Registrable Securities are covered by a Registration Statement on Form S-3, such filings
shall have been made within the applicable time period prescribed for such filing under the Exchange Act.

 

(vi)             No
Suspension of Trading in or Notice of Delisting of Common Stock.  Trading in the Common Stock shall not have been
suspended by the Commission, the Trading Market or the FINRA (except for any suspension of trading of limited duration agreed
to by the Company, which suspension shall be terminated prior to the applicable Draw Down Exercise Date), the Company shall not
have received any final and non-appealable notice that the listing or quotation of the Common Stock on the Trading Market shall
be terminated on a date certain (unless, prior to such date certain, the Common Stock is listed or quoted on any other Trading
Market), and trading in securities generally as reported on the Trading Market shall not have been suspended or limited, nor shall
a banking moratorium have been declared either by the U.S. or New York State authorities (except for any suspension, limitation
or moratorium which shall be terminated prior to the applicable Draw Down Exercise Date), nor shall there have occurred any material
outbreak or escalation of hostilities or other national or international calamity or crisis that has had or would reasonably be
expected to have a material adverse change in any U.S. financial, credit or securities market that is continuing as of the applicable
Draw Down Exercise Date.

 

    	29

    	 

    

 

(vii)           Compliance
with Laws.  The Company shall have complied with all applicable federal, state and local governmental laws, rules,
regulations and ordinances in connection with the execution, delivery and performance of this Agreement and the other Transaction
Documents to which it is a party and the consummation of the transactions contemplated hereby and thereby, including, without
limitation, the Company shall have obtained all permits and qualifications required by any applicable state securities or “Blue
Sky” laws for the offer and sale of the Securities by the Company to the Investor and the subsequent resale of the Registrable
Securities by the Investor (or shall have the availability of exemptions therefrom).

 

(viii)         No
Injunction.  No statute, regulation, order, decree, writ, ruling or injunction shall have been enacted, entered,
promulgated, threatened or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation
of or which would materially modify or delay any of the transactions contemplated by the Transaction Documents.

 

(ix)             No
Proceedings or Litigation.  No action, suit or proceeding before any arbitrator or any court or governmental authority
shall have been commenced or threatened, and no inquiry or investigation by any governmental authority shall have been commenced
or threatened, against the Company or any Subsidiary, or any of the officers, directors or affiliates of the Company or any Subsidiary,
seeking to restrain, prevent or change the transactions contemplated by the Transaction Documents, or seeking material damages
in connection with such transactions.  

 

(x)               Aggregate
Limit.   The issuance and sale of the Shares issuable pursuant to such Draw Down Notice shall not violate Sections
3.1, 3.7 and 6.6 hereof.

 

(xi)             Securities
Authorized and Delivered.  The Shares issuable pursuant to such Draw Down Notice shall have been duly authorized
by all necessary corporate action of the Company. The Company shall have delivered all Shares relating to all prior Draw Down
Notices.

 

(xii)           Listing
of Securities.   All of the Securities that may be issued pursuant to this Agreement shall have been approved
for listing or quotation on the Trading Market as of the Closing Date, subject only to notice of issuance.

 

(xiii)         No
Material Adverse Effect.  No condition, occurrence, state of facts or event constituting a Material Adverse
Effect shall have occurred and be continuing.

 

(xiv)         No
Prohibited Transaction. The Company shall not have entered into any Prohibited Transaction.

 

(xv)           Intentionally
Left Blank.

 

    	30

    	 

    

  

ARTICLE
VIII

TERMINATION

 

Section 8.1.         
 Termination.  Unless earlier terminated as provided hereunder, this Agreement shall terminate automatically
on the earlier to occur of (i) the first day of the month next following the 36-month anniversary of the Effective
Date (it being hereby acknowledged and agreed that such term may not be extended by the parties hereto) and (ii) the date on which
the Investor shall have purchased or acquired shares of Common Stock pursuant to this Agreement equal to the Aggregate Limit.
Subject to Section 8.3, the Company may, provided that shares of Common Stock aggregating no less than twenty-five percent
(25%) of the Total Commitment shall have been sold by the Company to the Investor pursuant hereto, terminate this Agreement effective
upon one Trading Day’s prior written notice to the Investor in accordance with Section 10.4. Subject to Section
8.3, this Agreement may be terminated at any time by the mutual written consent of the parties, effective as of the date of
such mutual written consent unless otherwise provided in such written consent.

 

Section 8.2.         
 Other Termination.  Subject to Section 8.3, the Investor shall have the right to terminate this Agreement
effective upon one Trading Day’s prior written notice to the Company in accordance with Section 10.4, if: (i) any
condition, occurrence, state of facts or event constituting a Material Adverse Effect has occurred and is continuing; (ii) the
Registration Statement is not filed by the filing deadline (as described in the Registration Rights Agreement) or declared effective
within six (6) months of the date hereof, or the Company is otherwise in breach or default in any material respect under any of
the other provisions of the Registration Rights Agreement, and, if such failure, breach or default is capable of being cured,
such failure, breach or default is not cured within 10 Trading Days after notice of such failure, breach or default is delivered
to the Company pursuant to Section 10.4; (iii) while the Registration Statement is required to be maintained effective
pursuant to the terms of the Registration Rights Agreement and the Investor holds any Registrable Securities, the effectiveness
of the Registration Statement lapses for any reason (including, without limitation, the issuance of a stop order) or the Registration
Statement, the Prospectus or any Prospectus Supplement is otherwise unavailable to the Investor for the resale of all of the Registrable
Securities in accordance with the terms of the Registration Rights Agreement, and such lapse or unavailability continues for a
period of 20 consecutive Trading Days or for more than an aggregate of 60 Trading Days in any 365-day period, other than due to
acts of the Investor; (iv) trading in the Common Stock on the Trading Market shall have been suspended or the Common Stock shall
have failed to be listed or quoted on a Trading Market, and such suspension or failure continues for a period of 20 consecutive
Trading Days or for more than an aggregate of 60 Trading Days in any 365-day period; (v) the Company has filed for and/or is subject
to any bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings for relief under any bankruptcy
law or any law for the relief of debtors instituted by or against the Company or (vi) the Company is in material breach or default
of this Agreement, and, if such breach or default is capable of being cured, such breach or default is not cured within 10 Trading
Days after notice of such breach or default is delivered to the Company pursuant to Section 10.4. Unless notification thereof
is required elsewhere in this Agreement (in which case such notification shall be provided in accordance with such other provision),
the Company shall promptly (but in no event later than 24 hours) notify the Investor (and, if required under applicable law, including,
without limitation, Regulation FD promulgated by the Commission, or under the applicable rules and regulations of the Trading
Market, the Company shall publicly disclose such information in accordance with Regulation FD and the applicable rules and regulations
of the Trading Market) upon becoming aware of any of the events set forth in the immediately preceding sentence.

 

    	31

    	 

    

  

Section 8.3.         
 Effect of Termination.  In the event of termination by the Company or the Investor pursuant to Section
8.1 or 8.2, as applicable, written notice thereof shall forthwith be given to the other party as provided in Section
10.4 and the transactions contemplated by this Agreement shall be terminated without further action by either party. If the
Agreement is terminated by the Company, one million shares of the Common Stock held in escrow in accordance with the Escrow Agreement
shall be released to the Investor and the remaining six (6) million such shares shall be returned to the Company. If this Agreement
is terminated as provided in Section 8.1 or 8.2 herein, this Agreement shall become void and of no further force
and effect, except that (i) the provisions of Article V (Representations and Warranties of the Company), Article IX (Indemnification),
Article X (Miscellaneous) (excluding Section 10.1(v)) and this Article VIII (Termination) shall remain in full force and
effect indefinitely notwithstanding such termination, and, (ii) so long as the Investor owns any Securities, the covenants and
agreements of the Company contained in Article VI (Additional Covenants) shall remain in full force and notwithstanding such termination
for a period of six months following such termination. Notwithstanding anything in this Agreement to the contrary, no termination
of this Agreement by any party shall (i) become effective prior to the first Trading Day immediately following the Settlement
Date related to any pending Draw Down Notice that has not been fully settled in accordance with the terms and conditions of this
Agreement (it being hereby acknowledged and agreed that no termination of this Agreement shall limit, alter, modify, change or
otherwise affect any of the Company’s or the Investor’s rights or obligations under the Transaction Documents with
respect to any pending Draw Down, and that the parties shall fully perform their respective obligations with respect to any such
pending Draw Down under the Transaction Documents, provided  all of the conditions to the settlement thereof
set forth in Article VII are timely satisfied), or (ii) limit, alter, modify, change or otherwise affect the Company’s or
the Investor’s rights or obligations under the Registration Rights Agreement, all of which shall survive any such termination.
Nothing in this Section 8.3 shall be deemed to release the Company or the Investor from any liability for any breach or
default under this Agreement or any of the other Transaction Documents to which it is a party, or to impair the rights of the
Company and the Investor to compel specific performance by the other party of its obligations under the Transaction Documents
to which it is a party.

 

    	32

    	 

    

 

ARTICLE
IX

INDEMNIFICATION

 

Section 9.1.         
 Indemnification of Investor. In consideration of the Investor’s execution and delivery of this Agreement
and acquiring the Shares hereunder and in addition to all of the Company’s other obligations under the Transaction Documents
to which it is a party, subject to the provisions of this Section 9.1, the Company shall indemnify and hold harmless the
Investor, each of its directors, officers, shareholders, members, partners, employees, representatives, agents and advisors (and
any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding the lack of such title or
any other title), each Person, if any, who controls the Investor (within the meaning of Section 15 of the Securities Act or Section
20(a) of the Exchange Act), and the respective directors, officers, shareholders, members, partners, employees, representatives,
agents and advisors (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
the lack of such title or any other title) of such controlling Persons (each, an “Investor Party”),
from and against all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses (including all judgments,
amounts paid in settlement, court costs, reasonable attorneys’ fees and costs of defense and investigation) (collectively,
“Damages”) that any Investor Party may suffer or incur as a result of or relating to (a) any breach
of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction
Documents to which it is a party or (b) any action, suit, claim or proceeding (including for these purposes a derivative action
brought on behalf of the Company) instituted against such Investor Party arising out of or resulting from the execution, delivery,
performance or enforcement of the Transaction Documents, other than claims for indemnification within the scope of Section 6 of
the Registration Rights Agreement; provided, however, that (x) the foregoing indemnity shall not apply
to any Damages to the extent, but only to the extent, that such Damages resulted directly and primarily from a breach of any of
the Investor’s representations, warranties, covenants or agreements contained in this Agreement or the Registration Rights
Agreement, and (y) the Company shall not be liable under subsection (b) of this Section 9.1 to the extent, but only to
the extent, that a court of competent jurisdiction shall have determined by a final judgment (from which no further appeals are
available) that such Damages resulted directly and primarily from any acts or failures to act, undertaken or omitted to be taken
by such Investor Party through its fraud, bad faith, gross negligence, or willful or reckless misconduct.

 

The Company shall
reimburse any Investor Party promptly upon demand (with accompanying presentation of documentary evidence) for all legal and other
costs and expenses reasonably incurred by such Investor Party in connection with (i) any action, suit, claim or proceeding, whether
at law or in equity, to enforce compliance by the Company with any provision of the Transaction Documents or (ii) any other any
action, suit, claim or proceeding, whether at law or in equity, with respect to which it is entitled to indemnification under
this Section 9.1; provided  that the Investor shall promptly reimburse the Company for all such legal
and other costs and expenses to the extent a court of competent jurisdiction determines that any Investor Party was not entitled
to such reimbursement.

 

An Investor Party’s
right to indemnification or other remedies based upon the representations, warranties, covenants and agreements of the Company
set forth in the Transaction Documents shall not in any way be affected by any investigation or knowledge of such Investor Party.
Such representations, warranties, covenants and agreements shall not be affected or deemed waived by reason of the fact that an
Investor Party knew or should have known that any representation or warranty might be inaccurate or that the Company failed to
comply with any agreement or covenant. Any investigation by such Investor Party shall be for its own protection only and shall
not affect or impair any right or remedy hereunder.

 

To the extent that
the foregoing undertakings by the Company set forth in this Section 9.1 may be unenforceable for any reason, the Company shall
make the maximum contribution to the payment and satisfaction of each of the Damages which is permissible under applicable law.
 

 

    	33

    	 

    

  

Section 9.2.         
 Indemnification Procedures.  Promptly after an Investor Party receives notice of a claim or the commencement
of an action for which the Investor Party intends to seek indemnification under Section 9.1, the Investor Party will notify
the Company in writing of the claim or commencement of the action, suit or proceeding; provided, however,
that failure to notify the Company will not relieve the Company from liability under Section 9.1, except to the extent
it has been materially prejudiced by the failure to give notice.  The Company will be entitled to participate in the defense
of any claim, action, suit or proceeding as to which indemnification is being sought, and if the Company acknowledges in writing
the obligation to indemnify the Investor Party against whom the claim or action is brought, the Company may (but will not be required
to) assume the defense against the claim, action, suit or proceeding with counsel satisfactory to it.  After the Company
notifies the Investor Party that the Company wishes to assume the defense of a claim, action, suit or proceeding, the Company
will not be liable for any further legal or other expenses incurred by the Investor Party in connection with the defense against
the claim, action, suit or proceeding except that if, in the opinion of counsel to the Investor Party, it would be inappropriate
under the applicable rules of professional responsibility for the same counsel to represent both the Company and such Investor
Party.  In such event, the Company will pay the reasonable fees and expenses of no more than one separate counsel for all
such Investor Parties promptly as such fees and expenses are incurred. Each Investor Party, as a condition to receiving indemnification
as provided in Section 9.1, will cooperate in all reasonable respects with the Company in the defense of any action or
claim as to which indemnification is sought.  The Company will not be liable for any settlement of any action effected without
its prior written consent, which consent shall not be unreasonably withheld, delayed, denied, or conditioned. The Company will
not, without the prior written consent of the Investor Party, effect any settlement of a pending or threatened action with respect
to which an Investor Party is, or is informed that it may be, made a party and for which it would be entitled to indemnification,
unless the settlement includes an unconditional release of the Investor Party from all liability and claims which are the subject
matter of the pending or threatened action.

 

The remedies provided
for in this Article IX are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Investor
Party at law or in equity.

 

ARTICLE
X

MISCELLANEOUS

 

Section 10.1.      Fees
and Expenses. Each party shall bear its own fees and expenses related to the transactions contemplated by this Agreement; provided,
however, that the Investor has agreed to reimburse and pay directly to the Company’s counsel a registration statement
preparation fee in the aggregate amount of $15,000 (collectively, the “Registration Statement Preparation Fee”)
For the avoidance of doubt, the Registration Statement Fee (and any portion thereof) shall be non-refundable when
paid, regardless of whether any Draw Downs are issued by the Company or settled hereunder. The Company shall pay all U.S. federal,
state and local stamp and other similar transfer and other taxes and duties levied in connection with issuance of the Securities
pursuant hereto.

 

    	34

    	 

    

 

Section 10.2.      Specific
Enforcement, Consent to Jurisdiction, Waiver of Jury Trial. 

 

(i)                 The
Company and the Investor acknowledge and agree that irreparable damage would occur in the event that any of the provisions of
this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed
that either party shall be entitled to an injunction or injunctions to prevent or cure breaches of the provisions of this Agreement
by the other party and to enforce specifically the terms and provisions hereof (without the necessity of showing economic loss
and without any bond or other security being required), this being in addition to any other remedy to which either party may be
entitled by law or equity.

 

(ii)               Each
of the Company and the Investor (a) hereby irrevocably submits to the jurisdiction of the U.S. District Court and other courts
of the United States sitting in the State of New York for the purposes of any suit, action or proceeding arising out of or relating
to this Agreement, and (b) hereby waives, and agrees not to assert in any such suit, action or proceeding, any claim that it is
not personally subject to the jurisdiction of such court, that the suit, action or proceeding is brought in an inconvenient forum
or that the venue of the suit, action or proceeding is improper. Each of the Company and the Investor consents to process being
served in any such suit, action or proceeding by mailing a copy thereof to such party at the address in effect for notices to
it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.
Nothing in this Section 10.2 shall affect or limit any right to serve process in any other manner permitted by law.

 

(iii)             EACH
OF THE COMPANY AND THE INVESTOR HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL
BY JURY IN RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE
TRANSACTIONS CONTEMPLATED HEREBY OR DISPUTES RELATING HERETO. EACH OF THE COMPANY AND THE INVESTOR (A) CERTIFIES THAT NO REPRESENTATIVE,
AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF
LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN TO ENTER
INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 10.2.

 

Section 10.3.     
 Entire Agreement; Amendment.  The Transaction Documents set forth the entire agreement and understanding
of the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, negotiations
and understandings between the parties, both oral and written, with respect to such matters. There are no promises, undertakings,
representations or warranties by either party relative to subject matter hereof not expressly set forth in the Transaction Documents.
No provision of this Agreement may be amended by the parties from and after the date that is one Trading Day immediately preceding
the initial filing of the Registration Statement with the Commission. Subject to the immediately preceding sentence, no provision
of this Agreement may be amended other than by a written instrument signed by both parties hereto. The Disclosure Schedule and
all exhibits to this Agreement are hereby incorporated by reference in, and made a part of, this Agreement as if set forth in
full herein.  

 

    	35

    	 

    

 

Section 10.4.     
 Notices.  Any notice, demand, request, waiver or other communication required or permitted to be given hereunder
shall be in writing and shall be effective (a) upon hand delivery or facsimile (with facsimile machine confirmation of delivery
received) at the address or number designated below (if delivered on a business day during normal business hours where such notice
is to be received), or the first business day following such delivery (if delivered other than on a business day during normal
business hours where such notice is to be received) or (b) on the second business day following the date of mailing by express
courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur.
The address for such communications shall be:

 

If to the Company:

 

Soul and Vibe Interactive Inc. 

1660 South Hwy 100, Suite 500 

St. Louis Park, MN 55416 

Telephone Number: (763) 400-8040 

Fax: (763) 6455364

Attention: Peter Anthony Chiodo, CEO and President

 

With a copy (which
shall not constitute notice) to:

 

Sichenzia Ross Friedman Ference LLP 

61 Broadway

New York, NY 10006

Telephone Number: (212) 930-9700

Fax:  (212) 930-9725

Attention: Richard A. Friedman, Esq. 

 

If to the Investor:

 

Beaufort Capital Partners LLC

660 White Plains Road, Suite 455

Tarrytown, NY 10591

Telephone Number: (914) 332-4500

Fax: (914) 332-4577

Attention:  Leib Schaeffer, Managing Member

 

With a copy (which
shall not constitute notice) to:

 

Matthew McMurdo, Esq.

28 West 44th Street, 16th Floor

New York, NY 10036

Telephone Number: (917) 318-2865

Fax: (866) 606-8914

Attention: Matthew McMurdo

 

Either party hereto may from time to time
change its address for notices by giving at least 10 days advance written notice of such changed address to the other party hereto.

 

    	36

    	 

    

  

Section 10.5.     
 Waivers.  No provision of this Agreement may be waived by the parties from and after the date that is one
Trading Day immediately preceding the initial filing of the Registration Statement with the Commission. Subject to the immediately
preceding sentence, no provision of this Agreement may be waived other than in a written instrument signed by the party against
whom enforcement of such waiver is sought. No failure or delay in the exercise of any power, right or privilege hereunder shall
operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or
further exercises thereof or of any other right, power or privilege.

 

Section 10.6.     
 Headings.  The article, section and subsection headings in this Agreement are for convenience only and shall
not constitute a part of this Agreement for any other purpose and shall not be deemed to limit or affect any of the provisions
hereof. Unless the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine,
neuter, singular and plural forms thereof. The terms “including,” “includes,” “include” and
words of like import shall be construed broadly as if followed by the words “without limitation.”  The terms
“herein,” “hereunder,” “hereof” and words of like import refer to this entire Agreement instead
of just the provision in which they are found.

 

Section 10.7.     
 Construction. The parties agree that each of them and their respective counsel has reviewed and had an opportunity
to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to
be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents. In addition,
each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment
for any stock splits, stock combinations, stock dividends, recapitalizations and other similar transactions that occur on or after
the date of this Agreement. Any reference in this Agreement to “Dollars” or “$” shall mean the lawful
currency of the United States of America.

 

Section 10.8.     
 Successors and Assigns.  This Agreement shall be binding upon and inure to the benefit of the parties and
their respective successors and assigns. The Company may not assign this Agreement or any rights or obligations hereunder to any
Person without the prior written consent of the Investor, which may be withheld or delayed in the Investor’s sole discretion,
including by any Fundamental Transaction. The Investor may not assign its rights or obligations under this Agreement.

 

Section 10.9.     
 No Third Party Beneficiaries.  Except as expressly provided in Article IX, this Agreement is intended only
for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the benefit of, nor
may any provision hereof be enforced by, any other Person.

 

Section 10.10. 
 Governing Law.  This Agreement shall be governed by and construed in accordance with the internal procedural
and substantive laws of the State of New York, without giving effect to the choice of law provisions of such state that would
cause the application of the laws of any other jurisdiction.  

 

    	37

    	 

    

  

Section 10.11. 
 Survival.  The representations, warranties, covenants and agreements of the Company and the Investor contained
in this Agreement shall survive the execution and delivery hereof until the termination of this Agreement; provided, however,
that (i) the provisions of Article V (Representations and Warranties of the Company), Article VIII (Termination), Article IX (Indemnification)
and this Article X (Miscellaneous) (excluding Section 10.1(v)) shall remain in full force and effect indefinitely notwithstanding
such termination, and, (ii) so long as the Investor owns any Securities, the covenants and agreements of the Company contained
in Article VI (Additional Covenants), shall remain in full force and effect notwithstanding such termination for a period of six
months following such termination.

 

Section 10.12. 
 Counterparts.  This Agreement may be executed in counterparts, all of which taken together shall constitute
one and the same original and binding instrument and shall become effective when all counterparts have been signed by each party
and delivered to the other parties hereto, it being understood that all parties hereto need not sign the same counterpart. In
the event any signature is delivered by facsimile, digital or electronic transmission, such transmission shall constitute delivery
of the manually executed original and the party using such means of delivery shall thereafter cause four additional executed signature
pages to be physically delivered to the other parties within five days of the execution and delivery hereof.  Failure to
provide or delay in the delivery of such additional executed signature pages shall not adversely affect the efficacy of the original
delivery.

 

Section 10.13. 
 Publicity.  The Investor shall have the right to approve, prior to issuance or filing, any press release,
Commission filing or any other public disclosure made by or on behalf of the Company relating to the Investor, its purchases hereunder
or any aspect of the Transaction Documents or the transactions contemplated thereby; provided, however,
that except as otherwise provided in this Agreement, the Company shall be entitled, without the prior approval of the Investor,
to make any press release or other public disclosure (including any filings with the Commission) with respect thereto as is required
by applicable law and regulations (including the regulations of the Trading Market), so long as prior to making any such press
release or other public disclosure, if reasonably practicable, the Company and its counsel shall have provided the Investor and
its counsel with a reasonable opportunity to review and comment upon, and shall have consulted with the Investor and its counsel
on the form and substance of, such press release or other disclosure. For the avoidance of doubt, the Company shall not be required
to submit for review any such disclosure (i) contained in periodic reports filed with the Commission under the Exchange Act if
it shall have previously provided the same disclosure for review in connection with a previous filing or (ii) any Prospectus Supplement
if it contains disclosure that does not reference the Investor, its purchases hereunder or any aspect of the Transaction Documents
or the transactions contemplated thereby.

 

Section 10.14. 
 Severability.  The provisions of this Agreement are severable and, in the event that any court of competent
jurisdiction shall determine that any one or more of the provisions or part of the provisions contained in this Agreement shall,
for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability
shall not affect any other provision or part of a provision of this Agreement, and this Agreement shall be reformed and construed
as if such invalid or illegal or unenforceable provision, or part of such provision, had never been contained herein, so that
such provisions would be valid, legal and enforceable to the maximum extent possible.  

 

    	38

    	 

    

  

Section 10.15. 
 Further Assurances.  From and after the Closing Date, upon the request of the Investor or the Company, each
of the Company and the Investor shall execute and deliver such instrument, documents and other writings as may be reasonably necessary
or desirable to confirm and carry out and to effectuate fully the intent and purposes of this Agreement.

 

[Signature Page Follows] 

 

    	39

    	 

    

  

IN WITNESS WHEREOF,
the parties hereto have caused this Agreement to be duly executed by their respective authorized officer as of the date first
above written.

 

	 	SOUL AND VIBE INTERACTIVE INC.:
	 	 	 
	 	By:	 
	 	Name: Peter Anthony Chiodo
	 	Title: Chief Executive Officer 
	 	 	 
	 	BEAUFORT CAPITAL PARTNERS LLC, a New York limited
    liability company:
	 	 	 
	 	By:	 
	 	Name: Leib Schaeffer
	 	Title: Managing Member 

 

    	40

    	 

    

  

ANNEX
I TO THE

COMMON STOCK PURCHASE AGREEMENT

DEFINITIONS 

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common
control with a Person, as such terms are used in and construed under Rule 144.  With respect to the Investor, without limitation,
any Person owning, owned by, or under common ownership with the Investor, and any investment fund or managed account that is managed
on a discretionary basis by the same investment manager as the Investor will  be deemed to be an Affiliate.

 

“Aggregate
Limit” shall have the meaning assigned to such term in Section 2.1 hereof.

 

“Agreement”
shall have the meaning assigned to such term in the preamble hereof.

 

“Announcement
Date” shall have the meaning assigned to such term in Section 3.8 hereof.

 

“Broker-Dealer”
shall have the meaning assigned to such term in Section 6.17 hereof.

 

“Bylaws”
shall have the meaning assigned to such term in Section 5.3 hereof.

 

“Charter”
shall have the meaning assigned to such term in Section 5.3 hereof.

 

“Closing”
shall have the meaning assigned to such term in Section 2.2 hereof.

 

“Closing
Date” means the date of this Agreement.

 

“Code”
means the Internal Revenue Code of 1986, as amended.

 

“Commission”
means the U.S. Securities and Exchange Commission or any successor entity.

 

“Commission
Documents” shall mean (1) all reports, schedules, registrations, forms, statements, information and other documents
filed with or furnished to the Commission by the Company pursuant to the reporting requirements of the Exchange Act, including
all material filed or furnished pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act, and which hereafter shall be
filed with or furnished to the Commission by the Company, including, without limitation, the Current Report, (2) the Registration
Statement, as the same may be amended from time to time, the Prospectus and each Prospectus Supplement and (3) all information
contained in such filings and all documents and disclosures that have been and heretofore shall be incorporated by reference therein.

 

“Common
Stock” shall have the meaning assigned to such term in the recitals hereof.

 

“Company”
shall have the meaning assigned to such term in the preamble hereof.

 

    	1

    	 

    

  

“Current
Report” shall have the meaning assigned to such term in Section 2.3 hereof.

 

“Damages”
shall have the meaning assigned to such term in Section 9.1 hereof.

 

 “Disclosure
Schedule” shall have the meaning assigned to such term in the preamble to Article V hereof.

 

“Discount
Price” means a price equal to 71% of the average of the lowest trading price occurring on two separate days during
the applicable Pricing Period.  

 

“Draw
Down” means the transactions contemplated in Article III of this Agreement with respect to any Draw Down Notice
delivered by the Company in accordance with Article III of this Agreement.

 

“Draw
Down Amount” means the actual amount of proceeds received by the Company pursuant to a Draw Down under this Agreement.

 

“Draw
Down Amount Requested” shall mean the specific numbers of shares of Common Stock requested by the Company in a Draw
Down Notice delivered pursuant to Section 3.1, up to the Maximum Draw Down Amount Requested.

 

“Draw
Down Exercise Date” shall have the meaning assigned to such term in Section 3.1 hereof.

 

“Draw
Down Notice” shall have the meaning assigned to such term in Section 3.1 hereof.

 

“DTC”
means The Depository Trust Company, or any successor thereto.

 

“EDGAR”
means the Commission’s Electronic Data Gathering, Analysis and Retrieval System.

 

“Effective
Date” means the first Trading Day immediately following the date on which the initial Registration Statement filed
pursuant to Section 2(a) of the Registration Rights Agreement is declared effective by the Commission or becomes effective pursuant
to Section 8 of the Securities Act.

 

“Environmental
Laws” shall have the meaning assigned to such term in Section 5.18 hereof.

 

“ERISA”
shall mean the Employee Retirement Income Security Act of 1974, as amended.

 

“Escrow
Agreement” shall mean that certain escrow agreement, of even date herewith, by and among the Company, the Investor
and Matthew McMurdo, Esq.

 

    	2

    	 

    

  

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder.

 

“FCPA”
shall have the meaning assigned to such term in Section 5.36 hereof.

 

“Filing
Time” shall have the meaning assigned to such term in Section 3.8 hereof.  

 

“FINRA”
means the Financial Industry Regulatory Authority.

 

“GAAP”
shall mean generally accepted accounting principles in the United States of America as applied by the Company.

 

“Governmental
Licenses” shall have the meaning assigned to such term in Section 5.17 hereof.

 

“Indebtedness”
shall have the meaning assigned to such term in Section 5.11 hereof.

 

“Intellectual
Property” shall have the meaning assigned to such term in Section 5.17(b) hereof.

 

“Investment
Period” means the period commencing on the Effective Date and expiring on the date this Agreement is terminated
pursuant to Article VIII hereof.  

 

“Investor”
shall have the meaning assigned to such term in the preamble hereof.

 

“Investor
Party” shall have the meaning assigned to such term in Section 9.1 hereof.

 

“Knowledge”
means the actual knowledge of the Company’s Chief Executive Officer or Chief Financial Officer, after reasonable inquiry
of all officers, directors and employees of the Company who could reasonably be expected to have knowledge or information with
respect to the matter in question.

 

“Material
Adverse Effect” means (i) any condition, occurrence, state of facts or event having, or insofar as reasonably can
be foreseen would likely have, any material adverse effect on the legality, validity or enforceability of the Transaction Documents
or the transactions contemplated thereby, (ii) any condition, occurrence, state of facts or event having, or insofar as reasonably
can be foreseen would likely have, any effect on the business, operations, properties or financial condition of the Company that
is material and adverse to the Company and its Subsidiaries, taken as a whole, and/or (iii) any condition, occurrence, state of
facts or event that would, or insofar as reasonably can be foreseen would likely, prohibit or otherwise materially interfere with
or delay the ability of the Company to perform any of its obligations under any of the Transaction Documents to which it is a
party; provided, however, that none of the following, individually or in the aggregate, shall be taken
into account in determining whether a Material Adverse Effect has occurred or insofar as reasonably can be foreseen would likely
occur: (a) changes in conditions in the U.S. or global capital, credit or financial markets generally, including changes
in the availability of capital or currency exchange rates, provided such changes shall not have affected the Company in a materially
disproportionate manner as compared to other similarly situated companies; (b) changes generally affecting the mineral resources
exploration industry, provided such changes shall not have affected the Company in a materially disproportionate manner as compared
to other similarly situated companies; (c) any effect of the announcement of, or the consummation of the transactions contemplated
by, this Agreement and the other Transaction Documents on the Company’s relationships, contractual or otherwise, with customers,
suppliers, vendors, bank lenders, strategic venture partners or employees; and (d) the receipt of any notice that the Common Stock
may be ineligible to continue listing or quotation on the Trading Market, other than a final and non-appealable notice that the
listing or quotation of the Common Stock on the Trading Market shall be terminated on a date certain (unless, prior to such date
certain, the Common Stock is listed or quoted on any other Trading Market).

 

    	3

    	 

    

 

“Material
Agreements” shall have the meaning assigned to such term in Section 5.19 hereof.

 

“Maximum
Draw Down Amount Requested” shall have the meaning set forth in Section 3.4.

 

“Money
Laundering Laws” shall have the meaning assigned to such term in Section 5.37 hereof.

 

“OFAC”
shall have the meaning assigned to such term in Section 5.38 hereof.

 

“Ownership
Limitation” shall have the meaning assigned to such term in Section 3.7 hereof.

 

“Person”
means any person or entity, whether a natural person, trustee, corporation, partnership, limited partnership, limited liability
company, trust, unincorporated organization, business association, firm, joint venture, governmental agency or authority.

 

“Plan”
shall have the meaning assigned to such term in Section 5.24 hereof.

 

“Press
Release” shall have the meaning assigned to such term in Section 2.3 hereof.

 

“Pricing
Period” shall mean, with respect to each Draw Down, a period of five consecutive Trading Days immediately preceding
the date of the Draw Down Notice in accordance with Section 3.1 hereof.

 

“Prohibited
Transaction” shall have the meaning assigned to such term in Section 6.9 hereof.

 

“Prospectus”
means the prospectus in the form included in the Registration Statement, as supplemented from time to time by any Prospectus Supplement,
including the documents incorporated by reference therein.

 

“Prospectus
Supplement” means any prospectus supplement to the Prospectus filed with the Commission from time to time pursuant
to Rule 424(b) under the Securities Act, including the documents incorporated by reference therein.

 

    	4

    	 

    

 

“Registrable
Securities” shall have the meaning assigned to such term in the Registration Rights Agreement.

 

“Registration
Rights Agreement” shall have the meaning assigned to such term in the recitals hereof.

 

“Registration
Statement” shall have the meaning assigned to such term in the Registration Rights Agreement.

 

“Regulation
D” shall mean Regulation D promulgated by the Commission under the Securities Act.

 

“Required
Delivery Date” shall have the meaning assigned to such term in Section 10.1(iv) hereto.

 

“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from
time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect.

 

“Securities” means,
collectively, the Shares.

 

“Securities
Act” shall mean the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder.

 

“Settlement
Date” shall have the meaning assigned to such term in Section 3.5 hereof.

 

“Shares”
shall mean the whole shares of Common Stock that are and/or may be purchased by the Investor under this Agreement pursuant to
one or more Draw Downs.

 

“Short
Sales” shall mean “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange
Act.

 

“SOXA”
shall mean the Sarbanes-Oxley Act of 2002 and the rules and regulations of the Commission thereunder.

 

“Subsidiary”
shall mean any corporation or other entity of which at least a majority of the securities or other ownership interest having ordinary
voting power for the election of directors or other persons performing similar functions are at the time owned directly or indirectly
by the Company and/or any of its other Subsidiaries.

 

“Total
Commitment” shall have the meaning assigned to such term in Section 2.1 hereof.

 

“Trading
Day” shall mean a full trading day (beginning at 9:30 a.m., New York City time, and ending at 4:00 p.m., New York
City time) on the Trading Market.

 

    	5

    	 

    

 

“Trading
Market” means the OTCQB operated by OTC Markets Group Inc.; provided, however, that in the
event the Common Stock is ever listed or quoted on the NASDAQ Global Market, the NASDAQ Global Select Market, the NASDAQ
Capital Market, the New York Stock Exchange, NYSE Arca, the NYSE MKT, or the OTCQX operated by OTC Markets Group Inc., then the
“Trading Market” shall mean such other market or exchange or any successor to the foregoing on which
the Common Stock is then listed or quoted.  

 

“Transaction
Documents” means, collectively, this Agreement (as qualified by the Disclosure Schedule) and the exhibits hereto,
the Registration Rights Agreement and each of the other agreements, documents, certificates and instruments entered into or furnished
by the parties hereto in connection with the transactions contemplated hereby and thereby.

 

    	6

    	 

    

 

EXHIBIT
A TO THE

COMMON STOCK PURCHASE AGREEMENT

FORM OF REGISTRATION RIGHTS AGREEMENT  

 

    	1

    	 

    

 

EXHIBIT
B TO THE

COMMON STOCK PURCHASE AGREEMENT

FORM OF DRAW DOWN NOTICE

 

Reference is made
to the Common Stock Purchase Agreement dated as of February 11, 2015 (the  “Purchase Agreement”)
between Soul and Vibe Interactive Inc., a corporation organized and existing under the laws of the State of Nevada (the “Company”),
and Beaufort Capital Partners LLC, a New York limited liability company. Capitalized terms used and not otherwise defined herein
shall have the meanings given such terms in the Purchase Agreement. In accordance with and pursuant to Section 3.1 of the Purchase
Agreement, the Company hereby issues this Draw Down Notice to exercise a Draw Down for the Draw Down Amount Requested indicated
below.

 

	Draw Down Amount Requested:
	 
	Pricing
    Period start date:	 
	Pricing
    Period end date:	 
	Settlement Date:	 

 

On behalf of the Company,
the undersigned hereby certifies to the Investor that (i) the above Draw Down Amount Requested does not exceed the Maximum Draw
Down Amount Requested, (ii) the sale of Shares pursuant to this Draw Down Notice shall not cause the Company to sell or the Investor
to purchase shares of Common Stock which, when aggregated with all purchases made by the Investor pursuant to all prior Draw Down
Notices issued under the Purchase Agreement, would exceed the Aggregate Limit, (iii) to the Company’s Knowledge, the sale
of Shares pursuant to this Draw Down Notice shall not cause the Company to sell or the Investor to purchase shares of Common Stock
which would cause the aggregate number of shares of Common Stock then beneficially owned (as calculated pursuant to Section 13(d)
of the Exchange Act and Rule 13d-3 promulgated thereunder) by the Investor and its Affiliates to exceed the Ownership Limitation,
(iv) as of the date hereof, the Company does not possess any material non-public information, and (v) the Company has performed,
satisfied and complied in all material respects with all covenants, agreements and conditions required by the Purchase Agreement
and the Registration Rights Agreement to be performed, satisfied or complied with by the Company at or prior to the date hereof
and shall perform, satisfy and comply in all material respects with all covenants, agreements and conditions required by the Purchase
Agreement and the Registration Rights Agreement to be performed, satisfied or complied with by the Company at or prior to the
applicable settlement date, including without limitation, delivery of all certificates and bring down opinions required to be
delivered by the Purchase Agreement.

 

    	1

    	 

    

  

	 Dated:	 	 	By:	 
	 	 	 	Name	 
	 	 	 	Title:	 
	 	 	 	 	 
	 	 	 	Address: 
	 	 	 	Facsimile No.
	AGREED AND ACCEPTED	 	 	 

 

	By:	 	 	 	 
	 	Name	 	 	 
	 	Title:	 	 	 

 

    	2

    	 

    

 

EXHIBIT
C TO THE

COMMON STOCK PURCHASE AGREEMENT

CERTIFICATE OF THE COMPANY

 

CLOSING
CERTIFICATE

 

_________ 20__

 

The undersigned, the
[___________] of Soul and Vibe Interactive Inc., a corporation organized and existing under the laws of the State of Nevada (the
“Company”), delivers this certificate in connection with the Common Stock Purchase Agreement, dated
as of February 11, 2015 (the “Agreement”), by and between the Company and Beaufort Capital Partners
LLC, a New York limited liability company (the “Investor”), and hereby certifies on the date
hereof that (capitalized terms used herein without definition have the meanings assigned to them in the Agreement):

 

1.        
Attached hereto as Exhibit A is a true, complete and correct copy of the Articles of Incorporation of the Company
as filed with the Secretary of State of the State of Nevada as amended to date. The Articles of Incorporation of the Company have
not been further amended or restated, and no document with respect to any amendment to the Articles of Incorporation of the Company
has been filed in the office of the Secretary of State of the State of Nevada since the date shown on the face of the state certification
relating to the Company’s Articles of Incorporation, which is in full force and effect on the date hereof, and no action
has been taken by the Company in contemplation of any such amendment or the dissolution, merger or consolidation of the Company.

 

2.        
Attached hereto as Exhibit B is a true and complete copy of the Bylaws of the Company, as amended and restated
through, and as in full force and effect on, the date hereof, and no proposal for any amendment, repeal or other modification
to the Bylaws of the Company has been taken or is currently pending before the Board of Directors or stockholders of the Company.

 

3.        
The Board of Directors of the Company has approved the transactions contemplated by the Transaction Documents; said approval has
not been amended, rescinded or modified and remains in full force and effect as of the date hereof.

 

4.        
Each person who, as an officer of the Company, or as attorney-in-fact of an officer of the Company, signed the Transaction Documents
to which the Company is a party, was duly elected, qualified and acting as such officer or duly appointed and acting as such attorney-in-fact,
and the signature of each such person appearing on any such document is his genuine signature.

 

IN WITNESS WHEREOF,
I have signed my name as of the date first above written.

 

	 	 
	 	Name:
	 	Title:

 

    	1

    	 

    

 

EXHIBIT
D TO THE

COMMON STOCK PURCHASE AGREEMENT

COMPLIANCE CERTIFICATE

 

In connection with
the issuance of shares of common stock of Soul and Vibe Interactive Inc., a corporation organized and existing under the laws
of the State of Nevada (the “Company”), pursuant to the Draw Down Notice, dated [_____________], delivered
by the Company to Beaufort Capital Partners LLC, a New York limited liability company (the “Investor”)
pursuant to Article III of the Common Stock Purchase Agreement, dated as of February 11, 2015, by and between the Company and
the Investor (the “Agreement”), the undersigned hereby certifies to the Investor as follows:

 

1.        
The undersigned is the duly appointed Chief Executive Officer of the Company.

 

2.        
Except as set forth in the attached Disclosure Schedule, the representations and warranties of the Company set forth in Article
V of the Agreement (i) that are not qualified by “materiality” or “Material Adverse Effect” are true and
correct in all material respects as of [insert Draw Down Exercise Date] and as of the date hereof with the same force and effect
as if made on such dates, except to the extent such representations and warranties are as of another date, in which case, such
representations and warranties are true and correct in all material respects as of such other date and (ii) that are qualified
by “materiality” or “Material Adverse Effect” are true and correct as of [insert Draw Down Exercise Date]
and as of the date hereof with the same force and effect as if made on such dates, except to the extent such representations and
warranties are as of another date, in which case, such representations and warranties are true and correct as of such other date.

 

3.        
The Company has performed, satisfied and complied in all material respects with all covenants, agreements and conditions required
by the Agreement and the Registration Rights Agreement to be performed, satisfied or complied with by the Company at or prior
to [insert Draw Down Exercise Date] and the date hereof.

 

4.        
The Shares issuable on the date hereof in respect of the Draw Down Notice referenced above shall be delivered electronically by
crediting the Investor’s or its designees’ account at DTC through its Deposit/Withdrawal at Custodian (DWAC) system,
and shall be freely tradable and transferable and without restriction on resale.

 

5.        
As of [insert Fixed Request Exercise Date] and the date hereof, the Company did not and does not possess any material non-public
information.

 

Capitalized terms
used but not otherwise defined herein shall have the meanings assigned to them in the Agreement.

 

The undersigned has
executed this Certificate this [___] day of [___________], 20[__].

 

	 	By:	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 

 

    	1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00240-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00240-of-00352.parquet"}]]